Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1700
interventional 1234
Observational 446
Registry 20

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 461
Drug|placebo 363
Biological 85
Other 67
Behavioral 56
Biological|placebo 47
Device 31
Biological|Drug 23
Biological|Drug|placebo 20
Procedure 16
Device|Drug 6
Dietary Supplement 6
Diagnostic Test 5
Dietary Supplement|placebo 5
Drug|Other 4
Drug|Procedure 4
Behavioral|Other 3
Device|Procedure 3
Dietary Supplement|Drug 3
Biological|Device 2
Dietary Supplement|Other 2
Drug|Other|placebo 2
Genetic 2
Genetic|placebo 2
Other|Procedure 2
Radiation 2
Behavioral|Dietary Supplement 1
Biological|Combination Product|placebo 1
Biological|Diagnostic Test 1
Biological|Other 1
Device|Other 1
Diagnostic Test|Drug 1
Diagnostic Test|Other 1
Dietary Supplement|Drug|placebo 1
Drug|Radiation 1
NA 1
Other|placebo 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 227
NA 129
Japan 60
China 54
France 41
United Kingdom 35
Korea, Republic of 32
Germany 26
Netherlands 17
United States|Canada 16
Canada 14
Denmark 14
Sweden 11
Belgium 10
Brazil 10
Egypt 10
Russian Federation 9
Italy 8
Norway 8
Australia 7
Taiwan 7
Turkey 7
Austria 6
India 6
Spain 6
United States|Poland 6
United States|Puerto Rico 6
Iran, Islamic Republic of 5
Japan|Korea, Republic of|Taiwan 5
Singapore 5
United States|Germany 5
Israel 4
Mexico 4
Pakistan 4
Poland 4
Switzerland 4
Finland 3
France|Monaco 3
Greece 3
Hungary 3
Ireland 3
United States|United Kingdom 3
Belgium|Czechia|France|Hungary|Poland 2
Bulgaria 2
Denmark|Norway 2
Indonesia 2
Malaysia 2
Moldova, Republic of 2
Morocco 2
Tunisia 2
Ukraine 2
United States|Argentina|Australia|Austria|Belgium|Canada|Colombia|Czechia|France|Germany|Hungary|Ireland|Italy|Mexico|Monaco|Netherlands|Poland|Romania|Spain|Sweden|Switzerland|United Kingdom 2
United States|Argentina|Brazil|Bulgaria|Colombia|Czechia|Estonia|Germany|Hungary|Korea, Republic of|Latvia|Lithuania|Mexico|Poland|Romania|Russian Federation|Taiwan|United Kingdom 2
United States|Australia|Canada|Colombia|Germany|Israel|Mexico|Russian Federation|South Africa|United Kingdom 2
United States|Belgium|Bulgaria|Colombia|Czechia|Hungary|Mexico|Poland 2
United States|Belgium|Czech Republic|Germany|Puerto Rico|Romania|Slovakia 2
United States|Belgium|United Kingdom 2
United States|Canada|Mexico 2
United States|Hungary 2
United States|Mexico 2
Argentina 1
Argentina|Australia|Austria|Brazil|Bulgaria|Canada|China|France|Germany|Hungary|Israel|Mexico|Singapore|Slovakia|Switzerland|Thailand|Italy 1
Argentina|Australia|Austria|Brazil|Bulgaria|Canada|France|Germany|Hong Kong|Hungary|Israel|Italy|Mexico|Singapore|Slovakia|Switzerland|Thailand 1
Argentina|Australia|United States|Brazil|Canada|Czech Republic|Denmark|Korea, Republic of|Mexico|Peru|Poland|Puerto Rico|Russian Federation|South Africa|Spain|Sweden|Switzerland 1
Argentina|Belgium|Bulgaria|Chile|Croatia|France|Romania 1
Argentina|Brazil|Chile|Colombia|Costa Rica|Ecuador|Mexico|Peru|Uruguay|Venezuela 1
Argentina|Brazil|Chile|Colombia|Ecuador|El Salvador|Mexico|Peru|Uruguay|Venezuela 1
Argentina|Brazil|China 1
Argentina|Brazil|Colombia|Dominican Republic|Mexico|Venezuela 1
Argentina|Brazil|Hungary|Mexico|Poland|Romania|Russian Federation|United Kingdom 1
Argentina|Bulgaria|Chile|Colombia|Czech Republic|Estonia|Germany|Hungary|Poland|Russian Federation|Serbia|South Africa|Spain|Ukraine 1
Argentina|Bulgaria|Chile|Czech Republic|Hungary|Korea, Republic of|Poland|Russian Federation|Singapore|Ukraine 1
Argentina|Chile|Colombia|Mexico|Panama 1
Argentina|Colombia|Czech Republic|France|Greece|Hungary|Israel|Mexico|Portugal|Russian Federation|Serbia|Slovakia|Spain|United Kingdom 1
Argentina|United States|Australia|Brazil|Bulgaria|Canada|Colombia|Greece|Guatemala|Hungary|Israel|Malaysia|Mexico|New Zealand|Panama|Philippines|Poland|Russian Federation|South Africa|Spain|Switzerland|Thailand 1
Australia|Austria|Belgium|Czech Republic|Denmark|Finland|France|Germany|Greece|Israel|Italy|Netherlands|Norway|Poland|Portugal|Romania|Spain|Sweden|United Kingdom 1
Australia|Belgium|Canada|Czech Republic|Germany|Israel|Italy|Netherlands|Poland|Spain|United Kingdom 1
Australia|Brazil|Chile|Czech Republic|Estonia|India|Korea, Republic of|Peru|Poland|Russian Federation|South Africa|Spain 1
Australia|Canada|Czech Republic|France|Greece|Hungary|Italy|Netherlands|Poland|Portugal|Romania|Saudi Arabia|Spain|United Kingdom 1
Australia|Canada|Czech Republic|India|Poland|Slovakia 1
Australia|Canada|Germany 1
Australia|France|Germany|Russian Federation|United Kingdom 1
Australia|New Zealand|Russian Federation|Serbia|Ukraine 1
Austria|Canada|Finland|United Kingdom 1
Austria|Czechia|Russian Federation|Switzerland 1
Austria|France|Germany|Italy|Poland 1
Belarus|India|Russian Federation 1
Belarus|India|Russian Federation|Ukraine 1
Belarus|Russian Federation 1
Belgium|Bosnia and Herzegovina|Bulgaria|Czechia|Estonia|Georgia|Latvia|Poland|Spain|Ukraine 1
Belgium|Brazil|Canada|China|Colombia|Costa Rica|Croatia|Czech Republic|Ecuador|Estonia|France|Germany|Greece|Guatemala|Hong Kong|India|Korea, Republic of|Latvia|Lithuania|Netherlands|Panama|Peru|Portugal|Russian Federation|Serbia|Singapore|South Africa|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
Belgium|Bulgaria|Georgia|Germany|Hungary|Mexico|Moldova, Republic of|North Macedonia|Poland|Romania|Serbia|Spain 1
Belgium|Bulgaria|Georgia|Latvia|Lithuania|Poland|Romania|Serbia|Sweden|United Kingdom 1
Belgium|Canada|Czechia|Hungary|Poland|Spain|United Kingdom 1
Belgium|Czech Republic 1
Belgium|Czech Republic|Germany|Hungary|Netherlands|Poland|Romania|Ukraine 1
Belgium|Georgia|Hungary|Lebanon|Macedonia, The Former Yugoslav Republic of|Moldova, Republic of|Poland|Russian Federation|Serbia|Ukraine 1
Belgium|Germany|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|Hungary|Ireland|Netherlands|Spain|United Kingdom 1
Belgium|Luxembourg 1
Belgium|Netherlands|Poland|Russian Federation|Ukraine 1
Belgium|Poland 1
Belgium|Romania 1
Belgium|Spain 1
Bosnia and Herzegovina 1
Bosnia and Herzegovina|Bulgaria|Georgia|Hungary|Moldova, Republic of|Poland|Serbia 1
Bosnia and Herzegovina|Canada|Israel|Moldova, Republic of|Poland|Romania|Serbia 1
Bosnia and Herzegovina|Croatia|Netherlands 1
Bosnia and Herzegovina|Georgia|Poland|Serbia|Ukraine 1
Brazil|China|Colombia|Czech Republic|Egypt|Hungary|Jordan|Lebanon|Malaysia|Mexico|Philippines|Qatar|Romania|Russian Federation|South Africa|Taiwan|Thailand|Ukraine|United Arab Emirates 1
Brazil|China|Korea, Republic of 1
Bulgaria|Canada|Czechia|Estonia|Germany|Hungary|Italy|Mexico|Poland|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
Bulgaria|Colombia|Czech Republic|Hungary|Italy|Latvia|Malta|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Ukraine 1
Bulgaria|Croatia|Czech Republic|Former Serbia and Montenegro|Poland|Russian Federation|Slovakia|Slovenia|Ukraine 1
Bulgaria|Croatia|Czechia|Romania|Russian Federation|Slovakia|Ukraine 1
Bulgaria|Croatia|Former Serbia and Montenegro|Poland|Russian Federation|Slovenia 1
Bulgaria|Croatia|Germany|Greece|Hungary|Poland|Serbia|Slovakia|South Africa 1
Bulgaria|Czech Republic|Poland|Romania 1
Bulgaria|Czechia|Estonia|Hungary|Japan|Latvia|Lithuania|Poland|Romania|Russian Federation|Ukraine 1
Bulgaria|Czechia|Germany|Hungary|Poland|United Kingdom 1
Bulgaria|Czechia|Israel|Poland|Serbia|Ukraine 1
Bulgaria|Czechia|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 1
Bulgaria|Germany|Netherlands|Poland|Ukraine 1
Bulgaria|Germany|Spain|Sweden|Ukraine 1
Bulgaria|Hungary|Latvia|Poland|Russian Federation|Serbia|Spain 1
Bulgaria|Israel 1
Bulgaria|Lithuania 1
Bulgaria|Moldova, Republic of|Poland|Romania 1
Bulgaria|Netherlands 1
Bulgaria|Russian Federation 1
Bulgaria|United States|Argentina|Australia|Belgium|Chile|Colombia|Czechia|France|Germany|Guatemala|Hungary|Israel|Latvia|Mexico|Moldova, Republic of|New Zealand|Poland|Romania|Russian Federation|Spain|Ukraine 1
Canada|Georgia|India|Poland|Russian Federation|Serbia 1
Canada|New Zealand|Spain 1
Canada|Russian Federation 1
Canada|Sweden 1
Canada|United States 1
Chile 1
China|Korea, Republic of|Taiwan 1
China|United States|Argentina|Australia|Brazil|Canada|Costa Rica|Czech Republic|Finland|France|Germany|Hong Kong|Mexico|Panama|Russian Federation|South Africa|Spain|Sweden|Thailand 1
Colombia 1
Croatia 1
Cuba 1
Czech Republic|Denmark|Estonia|Argentina|Brazil|Canada|France|Germany|Greece|Latvia|Lithuania|Netherlands|Norway|Romania|Russian Federation|Serbia|Spain|Switzerland|Turkey 1
Czech Republic|Denmark|Hungary|Poland|Romania|United Kingdom 1
Czech Republic|Germany|Hungary|Italy|Latvia|Poland|Spain 1
Czech Republic|Germany|Hungary|Lithuania|Romania|United Kingdom 1
Czech Republic|Germany|Hungary|Poland|Slovakia|Ukraine|United Kingdom 1
Czech Republic|Germany|Italy|Poland|Portugal|Romania|Spain|United Kingdom 1
Czech Republic|Germany|Netherlands|New Zealand|Poland|Spain 1
Czech Republic|Italy|Korea, Republic of|Portugal|Romania 1
Czech Republic|Latvia|Romania|Russian Federation|Slovakia|Ukraine 1
Czechia|Georgia|Poland|Russian Federation|Ukraine 1
Czechia|Hungary|Moldova, Republic of|Poland|Russian Federation|Slovakia|United Kingdom 1
Czechia|Hungary|Poland 1
Denmark|Finland|France|Germany|Italy|Netherlands|Norway|Sweden|United Kingdom 1
Denmark|Finland|Hungary|Iceland|Norway|Sweden 1
Denmark|Finland|Iceland|Netherlands|Norway|Sweden 1
Denmark|Finland|Norway|Sweden 1
Denmark|France|Germany|Hungary|Italy|Norway|Spain|United Kingdom 1
Denmark|Iceland 1
Denmark|Netherlands|Poland|Sweden 1
Denmark|Netherlands|United Kingdom 1
Finland|Sweden 1
France|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|Finland|Germany|Greece|Hungary|India|Ireland|Italy|Luxembourg|Netherlands|Poland|Portugal|Romania|Saudi Arabia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
France|Germany|Italy|Russian Federation|Serbia|Tunisia 1
France|Netherlands|Sweden|United Kingdom 1
France|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Croatia|Czechia|Denmark|Germany|Greece|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
France|United States|Argentina|Canada|Hungary|Italy|Japan|Mexico|South Africa 1
Georgia|Moldova, Republic of|Romania 1
Georgia|United States|Belgium|Bulgaria|Czechia|Germany|Hungary|Mexico|Moldova, Republic of|North Macedonia|Poland|Romania|Serbia|Spain 1
Georgia|United States|Bulgaria|Czechia|Germany|Hungary|Poland|Serbia|Slovakia 1
Germany|Austria|France|Italy|Poland 1
Germany|Denmark|Hong Kong|Italy|Norway|Poland|Spain|Sweden|United Kingdom 1
Germany|Hungary|Italy|Netherlands|Portugal|Romania|Slovakia 1
Germany|Hungary|Poland|Russian Federation 1
Germany|Hungary|United States|Argentina|Austria|Belgium|Brazil|Estonia|France|India|Italy|Romania|Spain|Turkey 1
Germany|Italy|Poland|Russian Federation|Spain|United Kingdom 1
Germany|Jordan 1
Germany|Korea, Republic of|Moldova, Republic of|South Africa 1
Germany|Netherlands|Switzerland 1
Germany|Poland 1
Germany|Portugal|Serbia 1
Germany|Russian Federation 1
Germany|Russian Federation|Ukraine 1
Germany|United Kingdom 1
Germany|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Costa Rica|Czechia|Dominican Republic|Hungary|India|Korea, Republic of|Malaysia|Mexico|New Zealand|Peru|Philippines|Poland|Puerto Rico|Russian Federation|Slovakia|Spain|Sweden|Taiwan|Thailand|Ukraine 1
Germany|United States|Argentina|Bulgaria|Czech Republic|Estonia|Hungary|Mexico|Poland|Romania|Russian Federation|Serbia|Slovakia|Ukraine 1
Germany|United States|Australia|Brazil|Bulgaria|Colombia|Czechia|Estonia|Georgia|Hungary|Japan|Korea, Republic of|Lithuania|Mexico|New Zealand|Peru|Poland|Russian Federation|Serbia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
Guatemala|Hungary|United States|Argentina|Australia|Austria|Bulgaria|Chile|Colombia|Germany|Latvia|Mexico|Moldova, Republic of|New Zealand|Poland|Romania|Russian Federation|Spain|Ukraine 1
Hong Kong 1
Hong Kong|India|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan|Thailand 1
Hong Kong|Korea, Republic of|Philippines 1
Hungary|Australia|Belgium|Brazil|Canada|China|Finland|France|Germany|Italy|Netherlands|New Zealand|Slovakia|South Africa|Spain|Taiwan|Thailand|United Kingdom 1
Hungary|Czech Republic 1
Hungary|Moldova, Republic of|Russian Federation|Ukraine 1
India|Philippines|Poland|Sri Lanka|United Kingdom 1
India|Ukraine 1
Iraq 1
Ireland|Israel|United States|Belgium|Canada|France|Germany|Italy|Netherlands|Norway|United Kingdom 1
Ireland|Portugal|Spain 1
Israel|Italy|Japan|India|Ireland|United States|Argentina|Australia|Belgium|Bulgaria|Canada|Czechia|Germany|Hong Kong|Hungary|Korea, Republic of|Mexico|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Ukraine|United Kingdom 1
Israel|Netherlands|Spain|France|Germany|United States|Austria|Canada|Finland|United Kingdom 1
Italy|Czech Republic|Hungary|Spain|United Kingdom 1
Japan|United States|Argentina|Australia|Austria|Belgium|Canada|Croatia|France|Germany|Korea, Republic of|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Puerto Rico|Russian Federation|Spain|Taiwan|United Kingdom 1
Kazakhstan 1
Kuwait|Qatar|Bahrain|Iran, Islamic Republic of|United Arab Emirates 1
Lithuania|Poland 1
Lithuania|United Kingdom 1
Macedonia, The Former Yugoslav Republic of 1
Mexico|United States|Argentina|Belgium|Brazil|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|South Africa|Spain|Taiwan 1
Mexico|United States|Bulgaria|Canada|Chile|Colombia|Croatia|Japan|Korea, Republic of|Lithuania|Malaysia|Poland|Romania|Russian Federation|Serbia|South Africa|Taiwan|Ukraine 1
Netherlands|Sweden 1
Netherlands|United States|Belgium|Germany|Italy|Russian Federation|Spain|Switzerland|Turkey 1
Norway|United States|Argentina|Australia|Belgium|Brazil|Canada|China|Costa Rica|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Iceland|Israel|Italy|Lithuania|Mexico|Netherlands|Panama|Peru|Portugal|Puerto Rico|Russian Federation|Serbia|Slovenia|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Panama 1
Philippines 1
Philippines|Colombia|Czech Republic|Argentina|Poland|Russian Federation|Thailand 1
Poland|Romania|Bulgaria|Colombia|Germany|Hungary|Mexico|New Zealand|Russian Federation|Serbia|Ukraine 1
Poland|United Kingdom 1
Poland|United States 1
Poland|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Chile|Colombia|Czech Republic|France|Germany|Guatemala|Hungary|Israel|Latvia|Mexico|Moldova, Republic of|New Zealand|Russian Federation|Spain|Ukraine 1
Poland|United States|Argentina|Australia|Belgium|Canada|Czech Republic|France|Mexico|Romania|Russian Federation|Slovakia 1
Poland|United States|Argentina|Australia|Canada|Chile|Germany|Hungary|Korea, Republic of|Mexico|New Zealand|Taiwan 1
Portugal 1
Romania 1
Romania|Russian Federation|Spain 1
Romania|Ukraine 1
Russian Federation|Spain|Switzerland|Turkey 1
Russian Federation|United States|Belgium|Croatia|Germany|Hungary|Poland|Puerto Rico|Romania|Serbia 1
Saudi Arabia 1
Serbia 1
Serbia|United Kingdom 1
Slovakia 1
South Africa 1
Spain|Sweden|Australia|Austria|Belgium|Chile|Colombia|Czech Republic|Former Serbia and Montenegro|France|Germany|Hungary|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|Taiwan|United Kingdom 1
Spain|United States|Australia|Austria|Bulgaria|Canada|Czechia|France|Germany|Greece|Hungary|Ireland|Italy|Mexico|Monaco|Poland|Portugal|Romania|Switzerland|United Kingdom 1
Spain|United States|Australia|Bosnia and Herzegovina|Bulgaria|Canada|Chile|Costa Rica|Croatia|Czech Republic|Denmark|Dominican Republic|Finland|Germany|Korea, Republic of|Mexico|Philippines|Poland|Slovakia|Thailand|United Kingdom 1
Sri Lanka 1
Taiwan|United States|Japan|Argentina|Australia|Belgium|Bulgaria|Canada|Chile|Czechia|France|Germany|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Thailand|Ukraine|United Kingdom 1
Thailand 1
Ukraine|United States|Argentina|Brazil|Bulgaria|Colombia|Mexico|Poland|Russian Federation|Serbia 1
United Kingdom|France|Germany|Ireland|Italy|Monaco|Netherlands|Poland|Qatar|Romania|Russian Federation|Spain|Switzerland 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Kazakhstan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|New Zealand|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Canada|Chile|Colombia|Czechia|Ecuador|Estonia|Finland|Germany|Greece|Guatemala|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Canada|Chile|Colombia|Czechia|Egypt|Estonia|Finland|Germany|Greece|Hungary|India|Korea, Republic of|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|China|Colombia|Costa Rica|Croatia|Czechia|Denmark|Dominican Republic|Finland|France|Germany|Greece|Hungary|India|Ireland|Italy|Korea, Republic of|Malaysia|Mexico|New Zealand|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Slovakia|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Croatia|Czechia|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|Ireland|Italy|Kazakhstan|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Chile|Colombia|Croatia|France|Germany|Japan|Korea, Republic of|Lithuania|Malaysia|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Chile|Czechia|Estonia|Greece|Hungary|Israel|Italy|Japan|Mexico|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|South Africa|Spain|Turkey|Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Canada|Chile|Hungary|India|Korea, Republic of|Malaysia|New Zealand|Philippines|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|France|Germany|Hungary|Mexico|Netherlands|New Zealand|Norway|Poland|Puerto Rico|Slovakia|South Africa|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|Denmark|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Spain|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Colombia|Czechia|Ecuador|Germany|Greece|Guatemala|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Mexico|New Zealand|Peru|Poland|Portugal|Romania|Russian Federation|Slovakia|Spain|Taiwan|Turkey|Ukraine 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Colombia|Czechia|Finland|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Monaco|Netherlands|Peru|Poland|Qatar|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|China|Colombia|Denmark|Finland|France|Germany|Greece|Guatemala|Hong Kong|Hungary|Ireland|Israel|Italy|Macedonia, The Former Yugoslav Republic of|Mexico|New Zealand|Panama|Peru|Philippines|Poland|Portugal|Puerto Rico|Russian Federation|Singapore|South Africa|Spain|Sweden|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Estonia|Germany|Greece|Guatemala|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Kazakhstan|Latvia|Lithuania|Mexico|New Zealand|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|Tunisia|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Czechia|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Latvia|Mexico|Netherlands|New Zealand|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Chile|Estonia|France|Hungary|India|Mexico|Peru|Poland|Slovakia|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|France|Germany|Greece|Hungary|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Russian Federation|South Africa|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Russian Federation|Taiwan|Ukraine 1
United States|Argentina|Australia|Belgium|Bulgaria|Canada|Chile|Croatia|Czech Republic|Israel|Latvia|Russian Federation|Ukraine 1
United States|Argentina|Australia|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Estonia|Finland|France|Hungary|Israel|Latvia|Lithuania|Mexico|New Zealand|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|Argentina|Australia|Belgium|Bulgaria|Canada|Chile|Czechia|Germany|Hong Kong|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Croatia|Czechia|Germany|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Ireland|Netherlands|South Africa|United Kingdom 1
United States|Argentina|Australia|Belgium|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Mexico|Poland|Spain|Switzerland|United Kingdom 1
United States|Argentina|Australia|Belgium|France|Germany|Mexico|Netherlands|Poland|Spain|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Canada|Chile|China|Colombia|Czechia|Finland|Hong Kong|Israel|Jordan|Lebanon|Malaysia|Mexico|Netherlands|New Zealand|Peru|Poland|Puerto Rico|Russian Federation|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Canada|Colombia|France|Germany|Guatemala|Hong Kong|Italy|Lithuania|Mexico|New Zealand|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Thailand|United Kingdom 1
United States|Argentina|Australia|Bulgaria|Colombia|Croatia|Hungary|India|Japan|Korea, Republic of|Lithuania|Malaysia|Mexico|New Zealand|Poland|Romania|Russian Federation|Slovakia|South Africa|Sri Lanka|Taiwan|Ukraine 1
United States|Argentina|Australia|Bulgaria|Colombia|Estonia|France|Hungary|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Australia|Canada|China|Denmark|France|Israel|Italy|Lithuania|Mexico|Norway|Peru|Portugal|Serbia|Slovenia|South Africa|Spain 1
United States|Argentina|Australia|Chile|Germany|Hungary|India|Mexico|Poland|Romania|Slovakia|Ukraine 1
United States|Argentina|Australia|Colombia|Germany|Hungary|Latvia|Lithuania|Malaysia|Malta|Mexico|New Zealand|Peru|Poland|Ukraine 1
United States|Argentina|Australia|Colombia|Hungary|Korea, Republic of|Lithuania|Malaysia|Mexico|New Zealand|Poland|Russian Federation|Ukraine 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Germany|Greece|India|Italy|Japan|Korea, Republic of|Mexico|Portugal|Puerto Rico|Russian Federation|South Africa|Sweden|United Kingdom 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Germany|Mexico|Poland|Puerto Rico 1
United States|Argentina|Austria|Belgium|Bulgaria|Canada|Chile|Costa Rica|Denmark|Finland|France|Germany|Greece|Hungary|India|Ireland|Italy|Korea, Republic of|Latvia|Mexico|Netherlands|New Zealand|Norway|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Austria|Belgium|Canada|Czech Republic|Germany|Poland|Puerto Rico|Spain 1
United States|Argentina|Austria|Brazil|Canada|France|Germany|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|South Africa|Spain|Taiwan 1
United States|Argentina|Belgium|Brazil|Canada|Czech Republic|France|Germany|Hungary|Israel|Italy|Mexico|Portugal|South Africa|Spain|United Kingdom 1
United States|Argentina|Belgium|Brazil|Czechia|Estonia|Finland|Hungary|Israel|Italy|Mexico|Netherlands|Norway|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Argentina|Belgium|Canada|China|Croatia|Czechia|France|Germany|Greece|Hungary|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Belgium|Canada|Colombia|Guatemala|Hungary|India|Italy|Japan|Mexico|Panama|Puerto Rico|Thailand|Turkey|United Kingdom 1
United States|Argentina|Belgium|Canada|Czechia|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Poland|South Africa|Spain|United Kingdom 1
United States|Argentina|Brazil|Bulgaria|Chile|Czech Republic|Hungary|Mexico|Poland|Slovakia|Spain|Sweden|Turkey 1
United States|Argentina|Brazil|Bulgaria|Colombia|Korea, Republic of|Mexico|Poland|Russian Federation|Serbia|Ukraine 1
United States|Argentina|Brazil|Colombia|Czechia|Germany|Hungary|Korea, Republic of|Mexico|Poland|Russian Federation|Turkey 1
United States|Argentina|Brazil|Czech Republic|Germany|Mexico|Poland 1
United States|Argentina|Brazil|Hungary|Peru|Poland|Romania 1
United States|Argentina|Bulgaria|Canada|Czechia|France|Germany|Greece|Hungary|Italy|Mexico|Poland|Portugal|South Africa|Spain 1
United States|Argentina|Bulgaria|Chile|Colombia|Czech Republic|Hungary|Poland|Russian Federation|Singapore|Ukraine 1
United States|Argentina|Bulgaria|Chile|Colombia|Czechia|Mexico|Poland|Russian Federation|Serbia|South Africa|Ukraine 1
United States|Argentina|Bulgaria|Colombia|Mexico|Peru|Poland|Romania|Russian Federation|Ukraine 1
United States|Argentina|Bulgaria|Czech Republic|Germany|Mexico|Serbia|United Kingdom 1
United States|Argentina|Bulgaria|Czech Republic|Mexico|Poland|Slovakia|Spain 1
United States|Argentina|Canada|Chile|Hungary|Japan|Mexico|Poland|Serbia|Spain 1
United States|Argentina|Canada|Chile|Peru 1
United States|Argentina|Canada|Czechia|Hungary|India|Italy|Latvia|Lithuania|Malaysia|Poland|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Canada|Estonia|Hungary|Lithuania|Mexico|Poland|Romania|Russian Federation|Serbia|South Africa 1
United States|Argentina|Canada|Mexico|South Africa 1
United States|Argentina|Chile|Croatia|Czech Republic|Hungary|Mexico|Poland|Puerto Rico 1
United States|Argentina|Chile|Germany|India|Korea, Republic of|Peru|Poland|Romania|Russian Federation|Taiwan 1
United States|Argentina|Czech Republic|France|Korea, Republic of|Mexico|Spain|Taiwan 1
United States|Argentina|Korea, Republic of|Mexico|Russian Federation|South Africa|Spain 1
United States|Argentina|Mexico|Peru|Puerto Rico 1
United States|Argentina|Mexico|Peru|South Africa 1
United States|Australia 1
United States|Australia|Austria|Belgium|Brazil|Canada|Chile|Germany|Hungary|India|Mexico|Poland|Puerto Rico|Romania 1
United States|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Ireland|Italy|Korea, Republic of|Puerto Rico|Spain|Taiwan 1
United States|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|Finland|France|Germany|Ireland|Italy|Netherlands|Norway|Slovakia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Korea, Republic of|Latvia|New Zealand|Poland|Portugal|Puerto Rico|Russian Federation|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Mexico|Slovakia|South Africa 1
United States|Australia|Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Switzerland|Turkey|United Kingdom 1
United States|Australia|Austria|Canada|Finland|Germany|Netherlands|New Zealand|Spain|United Kingdom 1
United States|Australia|Austria|Canada|France|Germany|Greece|Hungary|Ireland|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Czech Republic|Finland|Germany|Israel|Italy|Mexico|New Zealand|Poland|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Czech Republic|France|Germany|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|South Africa|Spain|United Kingdom 1
United States|Australia|Belgium|Brazil|Czech Republic|Finland|Germany|Greece|Mexico|Portugal|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Australia|Belgium|Bulgaria|Czechia|Germany|Hungary|Korea, Republic of|Mexico|Philippines|Poland|Russian Federation|Slovakia|South Africa|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|Finland|France|Germany|Italy|Korea, Republic of|Mexico|Poland|Russian Federation|South Africa|Sweden 1
United States|Australia|Belgium|Canada|France|Germany|Iceland|Italy|Mexico|Netherlands|Puerto Rico|Sweden|Switzerland|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Mexico|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belgium|France|Italy|New Zealand|Poland|Russian Federation|Spain 1
United States|Australia|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Czechia|Georgia|Germany|Guatemala|Hungary|Israel|Japan|Jordan|Korea, Republic of|Lithuania|Mexico|Morocco|Peru|Philippines|Poland|Romania|Russian Federation|Serbia|South Africa|Tunisia|Ukraine|United Kingdom 1
United States|Australia|Bosnia and Herzegovina|Bulgaria|Croatia|Czechia|Georgia|Germany|Hungary|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Ukraine 1
United States|Australia|Brazil|Bulgaria|Canada|Colombia|Czech Republic|Greece|India|Japan|Korea, Republic of|Mexico|Poland|Taiwan|Ukraine 1
United States|Australia|Brazil|Canada|Colombia|Costa Rica|Hong Kong|Mexico|Panama|Peru|Philippines|Taiwan|Ukraine 1
United States|Australia|Brazil|Canada|Estonia|Germany|Greece|Ireland|Mexico|New Zealand|Poland|South Africa|Spain|United Kingdom 1
United States|Australia|Brazil|China|Denmark|Finland|France|Greece|Italy|Mexico|Norway|Poland|Puerto Rico|South Africa|Spain|Switzerland 1
United States|Australia|Bulgaria|Canada|Czechia|Germany|Hungary|Poland|Spain 1
United States|Australia|Canada|Germany|Puerto Rico|United Kingdom 1
United States|Australia|Canada|United Kingdom 1
United States|Australia|Chile|China|Colombia|Croatia|Denmark|Finland|Germany|Greece|Malaysia|Mexico|Poland|Russian Federation|Slovakia|Spain|Sweden|Thailand|United Kingdom|Venezuela 1
United States|Australia|Finland|France|Germany|Italy|Netherlands|United Kingdom 1
United States|Australia|Mexico|South Africa 1
United States|Austria|Belgium|Canada|Germany|Greece|Sweden|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Spain 1
United States|Austria|Belgium|Czechia|Germany|Ireland|United Kingdom 1
United States|Austria|Brazil|France|Germany|Italy|Mexico|Peru|Portugal|Spain|Switzerland 1
United States|Belarus|France|Germany|Hungary|Israel|Japan|Poland|Russian Federation|South Africa|Spain|United Kingdom 1
United States|Belgium|Brazil|Canada|Germany|Italy|Mexico|Slovakia|Spain 1
United States|Belgium|Bulgaria|Chile|Czechia|Hungary|Israel|Latvia|Mexico|New Zealand|Poland|Puerto Rico|Russian Federation|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Belgium|Bulgaria|Czechia|Georgia|Germany|Hungary|Mexico|Moldova, Republic of|North Macedonia|Poland|Romania|Serbia|Spain 1
United States|Belgium|Canada|Czechia|Hungary|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Belgium|Canada|France|Germany|Ireland|Israel|Italy|Netherlands|Norway|United Kingdom 1
United States|Belgium|Canada|France|Germany|Ireland|Netherlands|Switzerland|United Kingdom 1
United States|Belgium|Canada|Germany|Hungary|Russian Federation|Serbia|South Africa|Switzerland 1
United States|Belgium|Colombia|Croatia|Germany|Hungary|Japan|Mexico|Netherlands|Romania|Russian Federation 1
United States|Belgium|Colombia|France|Germany|Italy|Peru 1
United States|Belgium|Czech Republic|France|Germany|Ireland|Italy|Mexico|Spain|United Kingdom 1
United States|Belgium|Czech Republic|Germany|Hungary|Japan|Korea, Republic of|Poland|Russian Federation|Slovakia|Taiwan 1
United States|Belgium|Germany|Italy|Netherlands|Spain 1
United States|Belgium|Germany|Netherlands|Singapore|Spain 1
United States|Belgium|Germany|Russian Federation|United Kingdom 1
United States|Bosnia and Herzegovina|Bulgaria|Czechia|Germany|Hungary|India|Korea, Republic of|Mexico|Poland|Spain 1
United States|Bosnia and Herzegovina|Bulgaria|Czechia|Lithuania|Poland|Russian Federation|Serbia|South Africa|Ukraine 1
United States|Brazil|Bulgaria|Canada|Colombia|Czech Republic|France|Germany|Hungary|Italy|Mexico|Romania|Russian Federation|Slovakia|Spain 1
United States|Brazil|Bulgaria|Chile|Colombia|Czech Republic|Dominican Republic|Germany|India|Malaysia|Mexico|Philippines|Poland|Puerto Rico|Russian Federation|Ukraine 1
United States|Brazil|Bulgaria|Chile|Croatia|Czech Republic|Germany|Greece|Hungary|Italy|Korea, Republic of|Mexico|Romania|Slovakia|Ukraine 1
United States|Brazil|Croatia|Denmark|Estonia|France|Germany|Greece|Israel|Italy|Latvia|Netherlands|Norway|Romania|Russian Federation|Serbia|Spain|Sweden|Thailand|United Kingdom 1
United States|Bulgaria|Canada|Chile|Czechia|Germany|Peru|Poland|Romania|Russian Federation|Spain|Ukraine 1
United States|Bulgaria|Canada|Czech Republic|Germany|Hungary|Poland|Romania|Russian Federation|Spain|United Kingdom 1
United States|Bulgaria|Canada|Hungary|Italy|Poland|Puerto Rico|Slovakia 1
United States|Bulgaria|Chile|Colombia|Germany|Hungary|Lithuania|Mexico|Moldova, Republic of|Poland|Romania|Russian Federation|Serbia|South Africa|Spain|Ukraine 1
United States|Bulgaria|Chile|Croatia|Czech Republic|Estonia|Israel|Latvia|Lithuania|Mexico|Poland|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|Bulgaria|Chile|Czechia|Hungary|Israel|Latvia|Mexico|Poland|Puerto Rico|Russian Federation|Slovakia|South Africa|Spain|Turkey|Ukraine 1
United States|Bulgaria|Chile|Estonia|Germany|Hungary|Korea, Republic of|Malaysia|New Zealand|Poland|Russian Federation|Serbia|Spain|Thailand|Ukraine 1
United States|Bulgaria|Chile|Estonia|Germany|Hungary|Korea, Republic of|Malaysia|Poland|Russian Federation|Serbia|Spain|Thailand|Ukraine 1
United States|Bulgaria|Chile|Germany|Hungary|Mexico|Peru|Poland|Romania|Spain 1
United States|Bulgaria|Colombia|Czechia|Germany|Hungary|India|Korea, Republic of|Malaysia|Mexico|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine 1
United States|Bulgaria|Colombia|Mexico|Poland|Romania 1
United States|Bulgaria|Croatia|Czechia|Estonia|Israel|Latvia|Lithuania|Poland|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|Bulgaria|Czech Republic|Germany|Poland|South Africa|Ukraine 1
United States|Bulgaria|Czech Republic|Hungary|Poland|Serbia 1
United States|Bulgaria|Czechia|Estonia|Germany|Hungary|Italy|Latvia|Lithuania|Mexico|Poland|Russian Federation|Serbia|Slovakia|Spain|United Kingdom 1
United States|Bulgaria|Czechia|Georgia|Moldova, Republic of|Poland|Ukraine 1
United States|Bulgaria|Czechia|Hungary|Mexico|Poland 1
United States|Bulgaria|Estonia|Germany|Hungary|Poland 1
United States|Bulgaria|Israel|Poland|Romania|Serbia|Ukraine 1
United States|Canada|Chile|Czechia|Germany|Peru|Poland|Romania|Russian Federation|Spain|Ukraine 1
United States|Canada|Croatia|Czech Republic|France|Italy|Mexico|Romania|Serbia|South Africa|Spain|Taiwan 1
United States|Canada|Czech Republic|Germany|India|Israel|Italy|Latvia|Lithuania|Portugal|Romania|Serbia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Canada|France 1
United States|Canada|France|Germany|Italy|Netherlands|Spain 1
United States|Canada|Germany|Hungary|Poland|United Kingdom 1
United States|Canada|Germany|United Kingdom 1
United States|Canada|Hungary|Italy|Mexico|Spain 1
United States|Canada|Hungary|Japan|Russian Federation|Serbia|South Africa|Switzerland 1
United States|Canada|Puerto Rico|United Kingdom 1
United States|Chile|Czech Republic|Korea, Republic of|Mexico|Poland|Spain 1
United States|Chile|Czechia|Estonia|Hungary|Poland|Russian Federation 1
United States|Chile|Czechia|Germany|Hungary|Israel|Korea, Republic of|Peru|Poland|Romania|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
United States|Chile|Mexico|Poland|Russian Federation|South Africa 1
United States|Croatia|Czechia|Hungary|India|Mexico|Poland|Romania|Ukraine 1
United States|Czech Republic|Germany|Korea, Republic of|Mexico|Poland|Russian Federation|Spain 1
United States|Czech Republic|Hungary|Netherlands|Poland|United Kingdom 1
United States|Czechia 1
United States|Czechia|Argentina|Austria|Belgium|Bosnia and Herzegovina|Canada|Chile|Croatia|Ecuador|France|Germany|Greece|Hungary|India|Israel|Italy|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Philippines|Poland|Romania|Russian Federation|Serbia|South Africa|Spain|Turkey|United Kingdom 1
United States|Czechia|Germany|Hungary|Italy|Malaysia|Mexico|Poland|Romania|Russian Federation|Serbia|Spain|United Kingdom 1
United States|Czechia|Hong Kong|Hungary|Korea, Republic of|Russian Federation|Serbia|Singapore|Slovakia|Spain|Taiwan|Turkey|Ukraine 1
United States|Czechia|Poland|Puerto Rico|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Czechia|Poland|Russian Federation|Ukraine 1
United States|Denmark|Estonia|Lithuania|Netherlands|South Africa 1
United States|Estonia|Lithuania|South Africa 1
United States|Germany|Hungary|Israel|Netherlands|Poland|Puerto Rico 1
United States|Germany|Hungary|Poland 1
United States|Germany|Hungary|Ukraine|United Kingdom 1
United States|Germany|Poland 1
United States|Hungary|Japan|Korea, Republic of|Mexico|Poland|Russian Federation 1
United States|Korea, Republic of 1
United States|Korea, Republic of|Moldova, Republic of 1
United States|Korea, Republic of|Spain 1
United States|Lithuania 1
United States|Netherlands 1
United States|New Zealand 1
United States|Russian Federation 1
United States|Taiwan 1

Sites per Study

Site_count Study_Count
1 549
2 55
3 21
4 27
5 27
6 19
7 17
8 19
9 15
10 24
11 10
12 13
13 7
14 6
15 11
16 8
17 13
18 7
19 8
20 4
21 6
22 7
23 2
24 9
25 12
26 3
27 7
28 8
29 3
30 10
31 7
32 7
33 6
34 4
35 6
36 5
37 3
38 10
39 8
40 7
41 8
42 1
43 3
44 3
45 4
46 1
47 2
48 6
49 5
50 3
51 6
52 3
53 4
54 2
55 5
56 2
57 3
58 2
59 2
60 4
61 3
62 2
63 3
64 2
65 2
66 1
67 3
68 3
69 3
70 3
71 2
72 2
73 3
74 2
75 2
76 2
77 3
78 1
79 2
80 2
81 1
82 4
83 3
84 2
86 3
87 1
88 2
89 1
90 1
91 3
92 5
93 1
94 2
95 1
96 1
97 1
98 1
100 2
103 2
104 2
106 1
109 1
110 1
111 1
112 1
113 1
114 1
115 2
117 3
121 1
123 1
124 1
125 1
127 1
133 1
134 1
136 3
137 1
138 1
141 3
142 1
143 1
146 2
147 2
148 1
150 1
152 1
153 3
154 2
155 1
157 1
160 1
161 1
164 1
167 1
168 1
170 1
171 1
175 2
176 1
178 2
181 1
183 1
184 1
187 1
188 1
195 1
196 1
201 2
204 1
205 1
213 2
215 1
217 1
222 1
227 1
236 1
237 1
262 1
267 1
282 1
290 1
295 1
304 2
335 1
341 1
345 1
370 1
411 1
418 1
428 1
469 1
1066 1

Phase

Phase Study_Count
Phase 3 337
Phase 2 287
N/A 203
Phase 4 190
Phase 1 160
Phase 1/Phase 2 34
Phase 2/Phase 3 21
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 242
2 503
3 162
4 112
5 47
6 29
7 14
8 4
9 4
10 2
11 2
12 3
13 1
14 1
15 1
NA 107

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 68.0 2.0000 4.00000 5.00000 6.0000 12.0000 6.0000 8.0000
1st Qu. 88.5 38.2500 19.00000 26.25000 60.0000 60.0000 119.5000 58.5000
Median 109.0 75.0000 30.00000 53.00000 121.0000 118.0000 302.0000 122.5000
Mean 109.0 277.9307 47.44025 86.14706 171.4421 214.9524 565.5642 476.2553
3rd Qu. 129.5 157.5000 61.00000 117.50000 242.0000 210.0000 602.0000 277.0000
Max. 150.0 25876.0000 439.00000 312.00000 813.0000 1675.0000 23498.0000 24081.0000

Trial Group Type

group_type Group_Count
Experimental 1782
Active Comparator 480
Placebo Comparator 433
NA 107
Other 104
No Intervention 66
Sham Comparator 12

Intervention Model

intervention_model Study_Count
Parallel Assignment 835
Single Group Assignment 296
Crossover Assignment 67
Factorial Assignment 14
NA 14
Sequential Assignment 8

Primary Purpose

primary_purpose Study_Count
Treatment 1022
Basic Science 45
Other 39
Supportive Care 33
Prevention 28
NA 26
Diagnostic 19
Health Services Research 19
Device Feasibility 2
Screening 1

Observational Studies

Studies by Country

Country Study_Count
NA 95
United States 73
France 41
Germany 22
United Kingdom 15
Japan 13
Italy 12
Spain 12
Greece 10
Korea, Republic of 10
Belgium 8
Canada 8
Egypt 8
China 7
Sweden 7
Australia 6
Netherlands 6
Switzerland 5
Austria 4
Denmark 4
Finland 4
Hungary 3
Portugal 3
Slovakia 3
Taiwan 3
Turkey 3
Belgium|Luxembourg 2
Brazil 2
India 2
Martinique 2
Serbia 2
Argentina 1
Argentina|Belgium|Colombia|Ecuador|Germany|Greece|Guatemala|Italy|Mexico|Panama|Portugal|Spain|Switzerland|Ukraine|United Kingdom|Uruguay 1
Argentina|Colombia|Korea, Republic of|Malaysia|Mexico|Philippines|Russian Federation|Thailand|Venezuela|Vietnam 1
Australia|Austria|Belgium|France|Germany|Greece|Italy|Netherlands|Portugal|Spain|United Kingdom 1
Australia|Austria|France|Germany|Greece|Italy|Monaco|Netherlands|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Greece|Ireland|Italy|Netherlands|Spain|Switzerland 1
Austria|Canada|France|Korea, Republic of|United Kingdom 1
Austria|France|Germany|Italy|United Kingdom 1
Austria|France|Germany|Netherlands|Spain|United Kingdom 1
Belgium|France|Germany|Greece|Italy|Netherlands|Norway|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Canada|Denmark|United Kingdom 1
Colombia|Peru 1
Costa Rica|Dominican Republic|Guatemala|Panama 1
Croatia|Czech Republic|Estonia|Russian Federation|Slovakia 1
Croatia|Hungary|Israel|Poland|Romania|Slovakia|Ukraine 1
Denmark|Norway|Sweden 1
Estonia 1
France|Canada|Colombia|Germany|Greece|Italy|Mexico|Monaco|Norway|Portugal|Spain|United Kingdom 1
France|Germany|Spain|Sweden|United Kingdom 1
Germany|United Kingdom 1
Indonesia 1
Iraq 1
Ireland 1
Ireland|United Kingdom 1
Israel 1
Jordan 1
Kuwait|Lebanon|Qatar|United Arab Emirates 1
Lebanon 1
Luxembourg 1
Malaysia 1
Mexico 1
Montenegro 1
Norway 1
Norway|Sweden 1
Peru 1
Poland 1
Romania 1
Russian Federation 1
Saudi Arabia|Kuwait|Qatar|Algeria|Egypt 1
Singapore 1
South Africa 1
Spain|Belgium|Finland|Germany|Netherlands|Norway|Switzerland|United Kingdom 1
United States|Argentina|Australia|Bulgaria|Turkey 1
United States|Argentina|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Hungary|Ireland|Israel|Netherlands|Norway|Poland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Brazil|Bulgaria|Canada|Chile|Czech Republic|Dominican Republic|Finland|Greece|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Poland|Puerto Rico|Slovakia|Spain|Ukraine 1
United States|Canada 1
United States|Canada|Denmark|France|Germany|Ireland|Israel|Italy|Netherlands|Norway 1
United States|Canada|United Kingdom 1
United States|Puerto Rico 1
United States|Spain 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 287
2 9
3 3
4 8
5 9
6 6
7 8
8 7
9 7
10 9
11 2
12 5
13 6
14 4
15 8
16 2
17 1
18 2
19 3
20 4
21 1
22 3
23 2
24 2
25 1
26 3
27 1
28 1
29 1
30 1
32 3
35 1
36 2
40 1
41 1
42 1
43 1
47 1
48 1
54 2
56 1
59 1
60 1
72 1
75 1
77 1
85 2
96 1
117 1
119 1
122 1
154 1
163 2
180 1
193 1
212 1
215 1
244 1
303 1
311 1
320 1
370 1
453 1
1723 1

Enrollment Metrics

Measure Observational
Min 1.0
1st Qu 81.5
Median 210.0
Mean 245574.4
3rd Qu 635.0
Max 99999999.0

Observation Model

observational_model Study_Count
Cohort 291
Case-Only 49
NA 38
Case-Control 34
Other 17
Case Control 12
Family-Based 2
Case-Crossover 1
Defined Population, Natural History 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 314
Retrospective 58
Cross-Sectional 54
NA 14
Other 4
Cross-Sectional, Prospective 1
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
United States 6
Denmark 3
Korea, Republic of 3
Canada 2
NA 2
Turkey 2
France 1
Tunisia 1

Sites per Study

Site_count Study_Count
1 16
3 1
10 1
11 1
85 1

Enrollment Metrics

Measure Registries
Min 70.00
1st Qu 363.50
Median 775.00
Mean 5087.05
3rd Qu 1700.00
Max 57053.00

Registry Model

observational_model Study_Count
Cohort 16
Other 2
Case-Control 1
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 17
Cross-Sectional 2
Other 1

Follow-up

target_duration Study_Count
5 Years 6
10 Years 3
1 Year 2
1 Day 1
12 Months 1
15 Years 1
16 Weeks 1
24 Months 1
24 Years 1
3 Months 1
3 Years 1
8 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00055055 Study of Families With Twins or Siblings Discordant for Rheumatic Disorders https://ClinicalTrials.gov/show/NCT00055055 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04454034 Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04454034 Enrolling by invitation Peking University Third Hospital 2020-12-31
NCT04434118 Hydroxychloroquine May Reduce Risk of COVID-19 Infection in Rheumatoid Arthritis Patients: https://ClinicalTrials.gov/show/NCT04434118 Enrolling by invitation Sadat City University 2020-06-30
NCT03763201 Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03763201 Recruiting Benha University 2020-09-15
NCT03378219 An Observational Study on Sarilumab-exposed Pregnancies https://ClinicalTrials.gov/show/NCT03378219 Recruiting Sanofi 2027-08-31
NCT03348046 Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan https://ClinicalTrials.gov/show/NCT03348046 Completed Hikma Pharmaceuticals LLC 2019-04-14
NCT03832374 Association Between Subtypes of Anti Citrullinated Peptide Antibodies and Lung Damage in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03832374 Recruiting University Hospital Center of Martinique 2020-06-30
NCT03449589 Effect of Smoking on Pain and Atherosclerosis in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03449589 Recruiting Vastra Gotaland Region 2020-11-30
NCT03339089 Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases https://ClinicalTrials.gov/show/NCT03339089 Recruiting AbbVie 2021-06-30
NCT03331393 The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03331393 Active, not recruiting Bristol-Myers Squibb 2020-05-14
NCT03294876 Rheumatoid Arthritis Adrenal Recovery Study https://ClinicalTrials.gov/show/NCT03294876 Recruiting University of Edinburgh 2020-08-01
NCT03291457 A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice https://ClinicalTrials.gov/show/NCT03291457 Completed Hoffmann-La Roche 2019-12-04
NCT03288584 Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03288584 Recruiting University of Athens 2020-12-31
NCT03285191 Subject Insights to Understand Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT03285191 Completed GlaxoSmithKline 2017-08-17
NCT03277989 INFINITYâ„¢Total Ankle Replacement Follow-up https://ClinicalTrials.gov/show/NCT03277989 Recruiting Wright Medical Technology 2030-10-31
NCT03274141 Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC) https://ClinicalTrials.gov/show/NCT03274141 Completed Bristol-Myers Squibb 2018-10-31
NCT03270982 Comprehensive Segmental Revision System https://ClinicalTrials.gov/show/NCT03270982 Recruiting Zimmer Biomet 2023-04-30
NCT03267147 PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS https://ClinicalTrials.gov/show/NCT03267147 Active, not recruiting Fraunhofer Institute for Molecular Biology and Applied Ecology 2021-04-30
NCT03266822 T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy https://ClinicalTrials.gov/show/NCT03266822 Completed Szeged University 2015-12-30
NCT03264703 Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World https://ClinicalTrials.gov/show/NCT03264703 Completed Eisai Inc. 2019-07-31
NCT03249467 Validation of the French Version of the Health Assessment Questionnaire II (HAQ-II) for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03249467 Completed Rennes University Hospital 2016-07-31
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03190746 Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity https://ClinicalTrials.gov/show/NCT03190746 Completed Keesler Air Force Base Medical Center 2017-06-01
NCT03188081 A Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous (SC) Abatacept https://ClinicalTrials.gov/show/NCT03188081 Recruiting Bristol-Myers Squibb 2019-08-04
NCT03149796 Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT03149796 Completed Carmel Medical Center 2013-05-01
NCT03124225 Ultrasound Utility in Routine Clinical Practise https://ClinicalTrials.gov/show/NCT03124225 Completed Barts & The London NHS Trust 2012-12-31
NCT03112213 Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment https://ClinicalTrials.gov/show/NCT03112213 Completed Hoffmann-La Roche 2018-07-17
NCT03106259 Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj https://ClinicalTrials.gov/show/NCT03106259 Active, not recruiting Kang Stem Biotech Co., Ltd. 2017-01-24
NCT03073109 Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions https://ClinicalTrials.gov/show/NCT03073109 Completed Pfizer 2019-09-16
NCT03063593 UK Infinity, Post-Market Clinical Follow-up Study https://ClinicalTrials.gov/show/NCT03063593 Active, not recruiting Wright Medical Technology 2029-04-29
NCT03006198 Tracking Biologics Along the Silk Road https://ClinicalTrials.gov/show/NCT03006198 Completed Janssen Pharmaceutica N.V., Belgium 2018-12-01
NCT02963402 Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab https://ClinicalTrials.gov/show/NCT02963402 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2018-10-01
NCT02932644 Vitamin D and Cardiovascular Events in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02932644 Completed Odense University Hospital 2016-10-31
NCT02930187 Ultrasound Evaluation of Remission in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02930187 Completed University Hospital, Grenoble 2016-04-30
NCT02927535 Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France https://ClinicalTrials.gov/show/NCT02927535 Completed Centre Hospitalier Universitaire de Nīmes 2016-09-30
NCT02927509 Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France https://ClinicalTrials.gov/show/NCT02927509 Completed Centre Hospitalier Universitaire de Nīmes 2016-09-30
NCT02924623 Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity https://ClinicalTrials.gov/show/NCT02924623 Completed Centre Hospitalier Universitaire de Nīmes 2018-03-01
NCT02915094 Kineret in the Treatment of Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02915094 Completed Swedish Orphan Biovitrum 2016-01-31
NCT02905175 Rheumatoid Arthritis Patients and Porphyromonas Gingivalis https://ClinicalTrials.gov/show/NCT02905175 Completed Centre Hospitalier Universitaire de Saint Etienne 2016-06-27
NCT02897817 Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02897817 Completed Nordic Pharma SAS 2017-12-31
NCT02894047 Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years https://ClinicalTrials.gov/show/NCT02894047 Completed Centre Hospitalier Universitaire, Amiens 2015-10-31
NCT02886689 C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France https://ClinicalTrials.gov/show/NCT02886689 Completed Central Hospital, Nancy, France 2010-12-31
NCT02885818 Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02885818 Completed University Hospital, Brest 2018-01-11
NCT02863653 Participation Restrictions in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02863653 Completed Federal University of Minas Gerais 2009-08-31
NCT02809833 Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine https://ClinicalTrials.gov/show/NCT02809833 Completed Hoffmann-La Roche 2012-03-31
NCT02794012 Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02794012 Completed University of Colorado, Denver 2017-12-31
NCT02758769 Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings https://ClinicalTrials.gov/show/NCT02758769 Recruiting Bristol-Myers Squibb 2023-09-30
NCT02750800 Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) https://ClinicalTrials.gov/show/NCT02750800 Completed AbbVie 2018-04-03
NCT02747277 Analysis of B Cells From Autoimmune Individuals https://ClinicalTrials.gov/show/NCT02747277 Recruiting University of Colorado, Denver 2026-05-31
NCT02730286 Activity Limitations in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02730286 Completed Federal University of Minas Gerais 2009-08-31
NCT02721004 Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02721004 Completed Hoffmann-La Roche 2014-12-31
NCT02699892 Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02699892 Completed Hoffmann-La Roche 2014-02-28
NCT02689115 NFKB1 and IKK Epsilon in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02689115 Completed Asociación Científica Latina A.C. 2014-06-30
NCT02686320 Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65 https://ClinicalTrials.gov/show/NCT02686320 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2023-07-03
NCT02679001 A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment. https://ClinicalTrials.gov/show/NCT02679001 Completed Hoffmann-La Roche 2017-12-07
NCT02668640 Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China https://ClinicalTrials.gov/show/NCT02668640 Completed AbbVie 2018-06-12
NCT02675218 Bone MicroArchitecture Abatacept (BMA2) https://ClinicalTrials.gov/show/NCT02675218 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2020-03-31
NCT02652299 Fibrocytes in Early and Longstanding Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02652299 Completed Odense University Hospital 2018-04-04
NCT02648035 EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02648035 Completed Hoffmann-La Roche 2018-12-20
NCT02641977 Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate https://ClinicalTrials.gov/show/NCT02641977 Completed Ruhr University of Bochum 2016-04-30
NCT02639988 Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years https://ClinicalTrials.gov/show/NCT02639988 Recruiting Assistance Publique - Hôpitaux de Paris 2024-04-13
NCT02632890 Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries https://ClinicalTrials.gov/show/NCT02632890 Completed Bristol-Myers Squibb 2017-04-28
NCT02622503 A Study on Rheumatoid Arthritis Patients Treated With Rituximab https://ClinicalTrials.gov/show/NCT02622503 Completed Hoffmann-La Roche 2008-08-31
NCT02627924 Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab https://ClinicalTrials.gov/show/NCT02627924 Completed AbbVie 2017-12-28
NCT02616380 Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan https://ClinicalTrials.gov/show/NCT02616380 Completed AbbVie 2017-11-23
NCT02608112 Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year https://ClinicalTrials.gov/show/NCT02608112 Completed Hoffmann-La Roche 2018-07-26
NCT02598466 Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa https://ClinicalTrials.gov/show/NCT02598466 Completed Bristol-Myers Squibb 2016-01-31
NCT02600468 Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg https://ClinicalTrials.gov/show/NCT02600468 Completed Bristol-Myers Squibb 2015-12-31
NCT02600455 Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL https://ClinicalTrials.gov/show/NCT02600455 Completed Bristol-Myers Squibb 2016-06-30
NCT02590562 An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients. https://ClinicalTrials.gov/show/NCT02590562 Completed Hoffmann-La Roche 2014-08-31
NCT02569736 Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation https://ClinicalTrials.gov/show/NCT02569736 Completed Association Aquitaine de Recherche Clinique en Rhumatologie 2016-09-30
NCT02565225 Mobile Medically Supervised Patient Management in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02565225 Completed Heinrich-Heine University, Duesseldorf 2016-07-31
NCT02556034 Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA. https://ClinicalTrials.gov/show/NCT02556034 Completed Centre de Rhumatologie de l’Est du Québec 2018-11-16
NCT02564770 A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia https://ClinicalTrials.gov/show/NCT02564770 Completed Hoffmann-La Roche 2012-02-29
NCT03389711 INCMNSZ - Rheumatoid Arthritis Cohort https://ClinicalTrials.gov/show/NCT03389711 Recruiting National Institute of Medical Sciences and Nutrition, Salvador Zubiran 2024-02-04
NCT02552940 An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice https://ClinicalTrials.gov/show/NCT02552940 Completed Hoffmann-La Roche 2017-10-23
NCT02544334 Oral Metagenomic Biomarkers in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02544334 Completed University of Florida 2019-08-08
NCT02534311 A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28) https://ClinicalTrials.gov/show/NCT02534311 Completed Hoffmann-La Roche 2015-12-01
NCT02507752 An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab https://ClinicalTrials.gov/show/NCT02507752 Completed Hoffmann-La Roche 2012-06-30
NCT03387423 Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03387423 Recruiting Pfizer 2023-02-11
NCT02500498 Safety Profile of Nulojix in Home Infusion Settings https://ClinicalTrials.gov/show/NCT02500498 Completed Bristol-Myers Squibb 2015-06-30
NCT02503046 Estimation of Pentraxin3 and PGingivalis Levels in Patients With Knee Joint and Gum Diseases https://ClinicalTrials.gov/show/NCT02503046 Completed Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 2015-11-30
NCT02486302 A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. https://ClinicalTrials.gov/show/NCT02486302 Completed Pfizer 2017-12-11
NCT02485483 Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants https://ClinicalTrials.gov/show/NCT02485483 Completed Hoffmann-La Roche 2015-07-31
NCT02476084 Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT02476084 Recruiting University of Oxford 2020-10-31
NCT02468986 Study of Venous Endothelial Cells in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02468986 Active, not recruiting University of Texas Southwestern Medical Center 2019-08-31
NCT02441920 Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02441920 Active, not recruiting University of Birmingham 2012-11-30
NCT02402894 Follow-up of Person-centered Care of Young Adults With Rheumatic Disease https://ClinicalTrials.gov/show/NCT02402894 Active, not recruiting Vastra Gotaland Region 2020-12-31
NCT02402686 Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT02402686 Completed Hoffmann-La Roche 2018-12-17
NCT02362074 Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02362074 Completed AbbVie 2020-03-06
NCT02350491 Study During Pregnancy of Expression of miRNAs in RA or SLE https://ClinicalTrials.gov/show/NCT02350491 Completed University Hospital, Strasbourg, France 2018-10-14
NCT02348086 Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02348086 Recruiting StemGenex 2019-05-31
NCT02346942 Factors Associated With Biologic DMARD Switching https://ClinicalTrials.gov/show/NCT02346942 Completed Bristol-Myers Squibb 2015-12-31
NCT02337244 Zimmer POLAR Persona - TKA (EMEA Study) https://ClinicalTrials.gov/show/NCT02337244 Recruiting Zimmer Biomet 2026-11-30
NCT02327650 To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations https://ClinicalTrials.gov/show/NCT02327650 Recruiting Shinshu University 2016-04-30
NCT02322801 Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker https://ClinicalTrials.gov/show/NCT02322801 Completed Hoffmann-La Roche 2011-11-30
NCT02313129 Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02313129 Completed Duke University 2017-01-24
NCT02296632 Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study https://ClinicalTrials.gov/show/NCT02296632 Completed Cedars-Sinai Medical Center 2015-08-31
NCT02288520 Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02288520 Completed Nordic Pharma SAS 2016-03-31
NCT02281747 Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries https://ClinicalTrials.gov/show/NCT02281747 Active, not recruiting National Institutes of Health Clinical Center (CC) 2022-05-31
NCT02287610 A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02287610 Completed Horizon Pharma Ireland, Ltd., Dublin Ireland 2015-10-31
NCT02251860 Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice https://ClinicalTrials.gov/show/NCT02251860 Active, not recruiting Hoffmann-La Roche 2020-07-31
NCT02252744 Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02252744 Completed Western University of Health Sciences 2014-06-30
NCT02234960 Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT02234960 Completed Hoffmann-La Roche 2016-07-31
NCT02217137 Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients https://ClinicalTrials.gov/show/NCT02217137 Completed Singapore National Eye Centre 2015-09-30
NCT02202837 Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice https://ClinicalTrials.gov/show/NCT02202837 Completed Pfizer 2017-04-24
NCT02182739 Observational Study of Meloxicam in Any Labeled Indication https://ClinicalTrials.gov/show/NCT02182739 Completed Boehringer Ingelheim 2001-12-31
NCT02180516 Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome https://ClinicalTrials.gov/show/NCT02180516 Completed Boehringer Ingelheim 2004-09-30
NCT02184065 Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT02184065 Completed Boehringer Ingelheim 2007-04-30
NCT02184052 Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions https://ClinicalTrials.gov/show/NCT02184052 Completed Boehringer Ingelheim 2005-03-31
NCT02169544 Post-marketing Study Assessing the Long-Term Safety of Abatacept https://ClinicalTrials.gov/show/NCT02169544 Completed Bristol-Myers Squibb 2017-02-28
NCT02122406 Depression and Anxiety in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02122406 Completed University of Pavia 2015-12-31
NCT02109666 Long Term Experience With Abatacept in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02109666 Completed Bristol-Myers Squibb 2016-02-29
NCT02111057 Perioperative Flare in RA: Characterization of Clinical and Biological Features https://ClinicalTrials.gov/show/NCT02111057 Completed Hospital for Special Surgery, New York 2017-05-09
NCT02101307 Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab) https://ClinicalTrials.gov/show/NCT02101307 Completed Hoffmann-La Roche 2017-05-22
NCT02094326 Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT02094326 Completed Fundación Andaluza de Reumatología 2014-10-31
NCT02096120 Full Mouth Disinfection and Antibiotics for Periodontitis in High or Moderate Disease Activity Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02096120 Completed University Hospital Inselspital, Berne 2017-08-01
NCT02090556 Long-term Experience With Abatacept SC in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02090556 Active, not recruiting Bristol-Myers Squibb 2019-10-30
NCT02064400 Pilot Study of Ultrasound in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02064400 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2014-07-31
NCT01313858 A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554) https://ClinicalTrials.gov/show/NCT01313858 Completed Merck Sharp & Dohme Corp. 2015-09-30
NCT01309282 An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB) https://ClinicalTrials.gov/show/NCT01309282 Completed Hoffmann-La Roche 2013-08-31
NCT01294722 A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti‐Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea https://ClinicalTrials.gov/show/NCT01294722 Completed Janssen Korea, Ltd., Korea 2012-08-31
NCT01288287 Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients https://ClinicalTrials.gov/show/NCT01288287 Completed UCB Pharma 2014-10-31
NCT01283399 An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01283399 Completed Hoffmann-La Roche 2014-04-30
NCT01282372 Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab https://ClinicalTrials.gov/show/NCT01282372 Completed AbbVie 2014-07-31
NCT01273519 Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab https://ClinicalTrials.gov/show/NCT01273519 Completed AbbVie 2013-01-31
NCT02051114 Discovering the Antecedents of Rheumatoid Arthritis Flare https://ClinicalTrials.gov/show/NCT02051114 Active, not recruiting Rockefeller University 2021-02-28
NCT02037737 Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting https://ClinicalTrials.gov/show/NCT02037737 Completed Bristol-Myers Squibb 2018-01-31
NCT02012764 The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ? https://ClinicalTrials.gov/show/NCT02012764 Recruiting University of Leeds 2020-01-31
NCT01981473 Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab https://ClinicalTrials.gov/show/NCT01981473 Completed Pfizer 2014-12-31
NCT01952509 A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01952509 Completed Hoffmann-La Roche 2016-09-30
NCT01947465 Immunogenicity and Safety of Vaccinations in Immunocompromised Persons https://ClinicalTrials.gov/show/NCT01947465 Completed University of Zurich 2015-12-31
NCT01918267 U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497) https://ClinicalTrials.gov/show/NCT01918267 Completed Hoffmann-La Roche 2017-10-10
NCT01921478 A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01921478 Completed Hoffmann-La Roche 2010-11-30
NCT01877239 Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria https://ClinicalTrials.gov/show/NCT01877239 Completed Pfizer 2016-01-07
NCT01876329 Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01876329 Completed Keesler Air Force Base Medical Center 2015-04-30
NCT01870908 Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01870908 Completed Astellas Pharma Inc 2015-03-31
NCT01866150 A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01866150 Completed Hoffmann-La Roche 2013-10-31
NCT01850966 Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01850966 Completed Eisai Inc. 2014-04-13
NCT01788098 Genetics and Mechanisms of Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01788098 Completed Slovak Academy of Sciences 2012-06-30
NCT01791205 ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01791205 Completed Hoffmann-La Roche 2014-10-31
NCT01783730 Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents https://ClinicalTrials.gov/show/NCT01783730 Completed AbbVie 2015-09-30
NCT01773681 Novel Imaging Markers for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01773681 Completed University of California, San Francisco 2018-03-31
NCT01770834 A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01770834 Completed Hoffmann-La Roche 2017-01-25
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01768858 Completed AbbVie 2017-08-13
NCT01764321 Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors https://ClinicalTrials.gov/show/NCT01764321 Active, not recruiting UCB Pharma 2020-08-31
NCT01756235 Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01756235 Completed AbbVie 2015-10-31
NCT01752309 The Predictive Value of Ultrasound in Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01752309 Completed Erasmus Medical Center 2013-07-31
NCT01741688 An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01741688 Completed Hoffmann-La Roche 2014-03-06
NCT01736189 Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01736189 Completed AbbVie 2018-04-16
NCT01707186 Pictorial Representation of Illness and Self Measure https://ClinicalTrials.gov/show/NCT01707186 Completed University of Oxford 2017-06-30
NCT01706874 Effect Assessment of Periodontal Prophylaxis on Rheumatoid Arthritis Activity. https://ClinicalTrials.gov/show/NCT01706874 Completed Assistance Publique - Hôpitaux de Paris 2016-09-07
NCT01706029 Pain Evaluation in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01706029 Completed University Hospital, Limoges 2014-12-31
NCT01705730 A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy https://ClinicalTrials.gov/show/NCT01705730 Completed Hoffmann-La Roche 2014-12-12
NCT01700543 Sidus(TM) Post Market Clinical Follow-up (PMCF) Study https://ClinicalTrials.gov/show/NCT01700543 Active, not recruiting Zimmer Biomet 2020-07-31
NCT01697202 Fatigue in Rheumatoid Arthritis - Longitudinal Study https://ClinicalTrials.gov/show/NCT01697202 Completed Göteborg University 2012-12-31
NCT01698515 Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases– Anti- TNF Substudy https://ClinicalTrials.gov/show/NCT01698515 Completed Johns Hopkins University 2016-06-30
NCT01692899 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice https://ClinicalTrials.gov/show/NCT01692899 Completed Pfizer 2011-09-30
NCT01688193 Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male https://ClinicalTrials.gov/show/NCT01688193 Completed Hanmi Pharmaceutical Company Limited 2012-12-31
NCT01683604 Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia https://ClinicalTrials.gov/show/NCT01683604 Completed Hoffmann-La Roche 2014-06-30
NCT01685424 Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) https://ClinicalTrials.gov/show/NCT01685424 Completed Merck Sharp & Dohme Corp. 2015-03-01
NCT01677416 Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet https://ClinicalTrials.gov/show/NCT01677416 Completed Federal University of São Paulo 2012-03-31
NCT01671059 A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra) https://ClinicalTrials.gov/show/NCT01671059 Completed Hoffmann-La Roche 2015-09-30
NCT01672970 A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01672970 Completed Hoffmann-La Roche 2015-01-31
NCT01670045 A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01670045 Completed Hoffmann-La Roche 2014-06-30
NCT01669902 An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01669902 Completed Hoffmann-La Roche 2014-09-30
NCT01667458 An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) https://ClinicalTrials.gov/show/NCT01667458 Completed Hoffmann-La Roche 2012-12-31
NCT01664117 An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy https://ClinicalTrials.gov/show/NCT01664117 Completed Hoffmann-La Roche 2013-06-30
NCT01664104 A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting https://ClinicalTrials.gov/show/NCT01664104 Completed Hoffmann-La Roche 2013-12-31
NCT01663506 A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) https://ClinicalTrials.gov/show/NCT01663506 Completed Hoffmann-La Roche 2014-09-30
NCT01649817 A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II) https://ClinicalTrials.gov/show/NCT01649817 Completed Hoffmann-La Roche 2013-05-31
NCT01646385 Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry https://ClinicalTrials.gov/show/NCT01646385 Completed Pfizer 2012-08-31
NCT01642706 Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments https://ClinicalTrials.gov/show/NCT01642706 Recruiting University Hospital, Montpellier 2020-10-31
NCT01640548 A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01640548 Completed Hoffmann-La Roche 2013-06-30
NCT01633346 Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01633346 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2016-07-31
NCT01623752 Prospective Evaluation of the Radiographic Efficacy of Enbrel https://ClinicalTrials.gov/show/NCT01623752 Completed Pfizer 2018-03-31
NCT01616641 Orofacial Evaluation in Women With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01616641 Completed Federal University of São Paulo NA
NCT01615419 An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01615419 Completed Hoffmann-La Roche 2013-11-30
NCT01617005 A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs) https://ClinicalTrials.gov/show/NCT01617005 Completed Hoffmann-La Roche 2014-09-30
NCT01613378 A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra) https://ClinicalTrials.gov/show/NCT01613378 Completed Hoffmann-La Roche 2014-10-31
NCT01613027 An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01613027 Completed Hoffmann-La Roche 2015-09-30
NCT01596348 Exercise Perceptions and Preferences Among Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01596348 Completed University of Lausanne 2011-11-30
NCT01592292 An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy https://ClinicalTrials.gov/show/NCT01592292 Completed Hoffmann-La Roche 2014-12-31
NCT01585064 Optimization of Treatment With Adalimumab (Humira) https://ClinicalTrials.gov/show/NCT01585064 Completed Lawson Health Research Institute 2009-12-31
NCT01583244 Korean Post-marketing Surveillance for Orencia® https://ClinicalTrials.gov/show/NCT01583244 Completed Bristol-Myers Squibb 2016-02-29
NCT01579006 Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01579006 Completed Hoffmann-La Roche 2014-03-31
NCT01577563 Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). https://ClinicalTrials.gov/show/NCT01577563 Completed AstraZeneca 2013-03-31
NCT01565122 An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) https://ClinicalTrials.gov/show/NCT01565122 Completed Hoffmann-La Roche 2014-05-31
NCT01564901 An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids https://ClinicalTrials.gov/show/NCT01564901 Completed Hoffmann-La Roche 2012-10-31
NCT01562327 A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01562327 Completed Hoffmann-La Roche 2014-03-31
NCT01558089 Good EULAR Response In Patients With Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01558089 Completed Pfizer 2015-05-31
NCT01557348 An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor https://ClinicalTrials.gov/show/NCT01557348 Completed Hoffmann-La Roche 2012-03-31
NCT01557322 Characterize Patients With Moderately Active Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT01557322 Completed Pfizer 2012-09-30
NCT01543594 Italian Registry of Arthritis on Biologic Therapy https://ClinicalTrials.gov/show/NCT01543594 Recruiting Gruppo Italiano Studio Early Arthritis 2020-05-31
NCT01543503 An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01543503 Completed Hoffmann-La Roche 2015-02-28
NCT01526434 Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol https://ClinicalTrials.gov/show/NCT01526434 Completed UCB Pharma 2014-03-31
NCT01519375 Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) https://ClinicalTrials.gov/show/NCT01519375 Completed AstraZeneca 2012-05-31
NCT01521884 Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy https://ClinicalTrials.gov/show/NCT01521884 Completed Pfizer 2014-02-28
NCT01511926 Descriptive Study in Patients Treated With Vimovoâ„¢, Including Registration of the Physicians’ Prescribing Patterns https://ClinicalTrials.gov/show/NCT01511926 Completed AstraZeneca 2014-03-31
NCT01499732 Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects https://ClinicalTrials.gov/show/NCT01499732 Completed Orrin M Troum, M.D. and Medical Associates 2012-11-30
NCT01483326 An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct) https://ClinicalTrials.gov/show/NCT01483326 Completed Hoffmann-La Roche 2017-06-19
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01482507 Completed Optimus Clinical Research 2014-12-31
NCT01474291 An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01474291 Completed Hoffmann-La Roche 2014-09-30
NCT01480440 Outcomes Study of the TM Reverse Shoulder System Used in Primary or Revision Reverse Total Shoulder Arthroplasty https://ClinicalTrials.gov/show/NCT01480440 Active, not recruiting Zimmer Biomet 2026-12-31
NCT01462162 A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01462162 Completed Hoffmann-La Roche 2013-11-30
NCT01438892 Impact Of RA Therapy Compliance On Patient-Reported Outcomes https://ClinicalTrials.gov/show/NCT01438892 Completed Pfizer 2013-01-31
NCT01432366 Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT01432366 Completed Pfizer 2013-12-31
NCT01402661 Corrona Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry https://ClinicalTrials.gov/show/NCT01402661 Enrolling by invitation Corrona, LLC. 2100-12-31
NCT01392001 An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) https://ClinicalTrials.gov/show/NCT01392001 Completed Hoffmann-La Roche 2013-04-30
NCT01394276 An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST) https://ClinicalTrials.gov/show/NCT01394276 Completed Hoffmann-La Roche 2013-04-30
NCT01388608 Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept https://ClinicalTrials.gov/show/NCT01388608 Completed University Hospital Muenster 2013-01-31
NCT01388309 An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs https://ClinicalTrials.gov/show/NCT01388309 Completed Hoffmann-La Roche 2013-03-31
NCT01387789 A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia https://ClinicalTrials.gov/show/NCT01387789 Completed AbbVie 2013-03-31
NCT01383421 Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP) https://ClinicalTrials.gov/show/NCT01383421 Completed AbbVie 2016-04-30
NCT01384461 An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE) https://ClinicalTrials.gov/show/NCT01384461 Completed Hoffmann-La Roche 2013-05-31
NCT01375478 An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01375478 Completed Hoffmann-La Roche 2012-04-30
NCT01362062 Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy https://ClinicalTrials.gov/show/NCT01362062 Completed Hoffmann-La Roche 2015-01-01
NCT01357018 Quality of Life in Chronic Arthritis https://ClinicalTrials.gov/show/NCT01357018 Completed Far Eastern Memorial Hospital 2012-12-31
NCT01345071 Preconceptional Counselling in Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01345071 Recruiting Erasmus Medical Center 2021-06-30
NCT01346501 Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069 https://ClinicalTrials.gov/show/NCT01346501 Completed AbbVie 2014-11-30
NCT01346488 Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment) https://ClinicalTrials.gov/show/NCT01346488 Completed AbbVie 2016-01-31
NCT01339481 A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept https://ClinicalTrials.gov/show/NCT01339481 Completed Astellas Pharma Inc 2011-10-31
NCT01338545 An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE) https://ClinicalTrials.gov/show/NCT01338545 Completed Hoffmann-La Roche 2012-09-30
NCT01337388 An Observational Study of RoActemra/Actemra (Tocilizumab) in Smoking Versus Non-Smoking Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01337388 Completed Hoffmann-La Roche 2013-10-31
NCT04416997 Rheumatoid Arthritis Hematological Indices https://ClinicalTrials.gov/show/NCT04416997 Recruiting Assiut University 2022-10-29
NCT04407559 COVID-SErology in Rheumatoid Arthritis (COVID-19) https://ClinicalTrials.gov/show/NCT04407559 Active, not recruiting University Hospital, Montpellier 2020-09-01
NCT04413448 Performance of CT Parameters Compared to Bone Mineral Density to Detect Bone Fragility in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04413448 Completed Central Hospital, Nancy, France 2020-01-01
NCT04393233 Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation https://ClinicalTrials.gov/show/NCT04393233 Recruiting University Hospital, Brest 2020-05-23
NCT04384068 The Safety and Effectiveness of Tocilizumab in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04384068 Recruiting Peking Union Medical College Hospital 2021-01-31
NCT04389320 Antimalarial and Covid 19 in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04389320 Completed Assiut University 2020-05-01
NCT04351399 Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351399 Completed University Hospital, Lille 2020-05-04
NCT04343378 Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04343378 Active, not recruiting University Hospital, Rouen 2023-04-30
NCT04340115 Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets https://ClinicalTrials.gov/show/NCT04340115 Recruiting AbbVie 2024-04-26
NCT04297475 The Clinical Feasibilityof a Multi-modal Photoacoustic/Ultrasonic Imaging System in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04297475 Recruiting Peking Union Medical College Hospital 2020-12-31
NCT04281602 Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy https://ClinicalTrials.gov/show/NCT04281602 Recruiting University Hospital, Caen 2023-01-02
NCT04267614 This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients. https://ClinicalTrials.gov/show/NCT04267614 Completed Pfizer 2018-12-01
NCT04267536 An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04267536 Recruiting AbbVie 2023-03-31
NCT04267380 A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day https://ClinicalTrials.gov/show/NCT04267380 Completed Pfizer 2019-08-31
NCT04227535 Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2 https://ClinicalTrials.gov/show/NCT04227535 Recruiting Assistance Publique - Hôpitaux de Paris 2027-03-01
NCT04210817 A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04210817 Recruiting ProgenaBiome 2023-03-31
NCT04201535 Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04201535 Recruiting Istituto Ortopedico Galeazzi 2020-09-30
NCT04188249 Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04188249 Recruiting Peking Union Medical College Hospital 2021-03-01
NCT04191395 Evolution and Treatments of Chronic Inflammatory Systemic Diseases https://ClinicalTrials.gov/show/NCT04191395 Recruiting Centre Hospitalier Universitaire de Besancon 2029-12-31
NCT04175886 Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project https://ClinicalTrials.gov/show/NCT04175886 Recruiting University Hospital, Lille 2023-03-31
NCT04139954 Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs https://ClinicalTrials.gov/show/NCT04139954 Recruiting Turkish League Against Rheumatism 2020-03-01
NCT04134169 Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202) https://ClinicalTrials.gov/show/NCT04134169 Recruiting Kang Stem Biotech Co., Ltd. 2025-08-11
NCT04089514 A Real-world Study of Imraldi® Use https://ClinicalTrials.gov/show/NCT04089514 Recruiting Biogen 2021-06-30
NCT04056234 Study of the Articular Microbiota in Rheumatoid Arthritis. https://ClinicalTrials.gov/show/NCT04056234 Completed University Hospital, Bordeaux 2013-02-22
NCT04047121 A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04047121 Completed Pfizer 2019-10-21
NCT04022525 Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic Approaches https://ClinicalTrials.gov/show/NCT04022525 Active, not recruiting Assiut University 2019-08-31
NCT04018001 Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR) https://ClinicalTrials.gov/show/NCT04018001 Completed Pfizer 2019-04-25
NCT03999528 14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03999528 Completed Al-Azhar University 2019-08-01
NCT03981900 IDentification of Factors Predictive of Tofacitinib’s Survival in Patient With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03981900 Recruiting Pfizer 2023-01-31
NCT03977415 Interstitial Lung Disease in Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03977415 Recruiting National Jewish Health 2020-02-01
NCT03980639 Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase https://ClinicalTrials.gov/show/NCT03980639 Recruiting University Hospital, Toulouse 2019-06-28
NCT03975790 Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX https://ClinicalTrials.gov/show/NCT03975790 Completed Pfizer 2018-10-02
NCT03971253 Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03971253 Recruiting Astellas Pharma Inc 2025-12-31
NCT03972098 Uromodulin in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03972098 Completed Istanbul Saglik Bilimleri University 2018-05-01
NCT03964649 Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics https://ClinicalTrials.gov/show/NCT03964649 Completed Pfizer 2020-04-06
NCT03953378 CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis https://ClinicalTrials.gov/show/NCT03953378 Completed Hospices Civils de Lyon 2018-12-31
NCT03960515 Cardiovascular Profiles in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03960515 Completed Centro Hospitalar do Porto 2019-04-05
NCT03952897 Quality of Life Related to Health in Spa Users https://ClinicalTrials.gov/show/NCT03952897 Active, not recruiting University of Castilla-La Mancha 2019-03-01
NCT03937271 Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome https://ClinicalTrials.gov/show/NCT03937271 Active, not recruiting Taipei Veterans General Hospital, Taiwan 2019-05-31
NCT03908086 Bloodstream Infections in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03908086 Completed Rigshospitalet, Denmark 2017-12-31
NCT03885037 Infliximab Biosimilar for Intravenous Drip Infusion 100 mg “Pfizer” Drug Use Investigation (Rheumatoid Arthritis) https://ClinicalTrials.gov/show/NCT03885037 Recruiting Pfizer 2025-03-12
NCT03841279 Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03841279 Recruiting Mayo Clinic 2021-07-31
NCT03810144 Impact of Guided Care With the Vectra DA Multi-biomarker Disease Activity (MBDA) Blood Test https://ClinicalTrials.gov/show/NCT03810144 Recruiting Myriad Genetic Laboratories, Inc. 2021-03-31
NCT03802890 Microbial Dysbiosis in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03802890 Enrolling by invitation Quadram Institute Bioscience 2021-04-30
NCT03785197 Effects of a Clinical Dietary Intervention During Inpatient Treatment https://ClinicalTrials.gov/show/NCT03785197 Recruiting Charite University, Berlin, Germany 2020-03-01
NCT03776682 Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study https://ClinicalTrials.gov/show/NCT03776682 Recruiting Mayo Clinic 2020-06-18
NCT03775824 Faecal Analyses in Rheumatoid Arthritis Therapy https://ClinicalTrials.gov/show/NCT03775824 Completed Region Skane 2018-11-01
NCT03770884 Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs) https://ClinicalTrials.gov/show/NCT03770884 Recruiting Assistance Publique - Hôpitaux de Paris 2019-07-31
NCT03754855 Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT03754855 Completed University Hospital, Bordeaux 2019-07-10
NCT03743181 Impact of Clinical Pharmacy Services Provided for Patients With Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03743181 Completed Ain Shams University 2019-10-10
NCT03719469 Circulating microRNAs as Novel Prognosis Biomarkers for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03719469 Completed King Saud University 2015-01-20
NCT03729349 Golimumab for Adherence in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03729349 Recruiting Janssen Inc. 2020-12-01
NCT03703817 Rheumatoid Arthritis Satisfaction Outcome Research https://ClinicalTrials.gov/show/NCT03703817 Completed Pfizer 2020-03-12
NCT03696173 Safety Study of Abatacept in Rheumatoid Arthritis Participants https://ClinicalTrials.gov/show/NCT03696173 Completed Bristol-Myers Squibb 2018-06-29
NCT03670667 A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents https://ClinicalTrials.gov/show/NCT03670667 Active, not recruiting Bristol-Myers Squibb 2019-03-29
NCT03666091 Study and Monitoring of Early Undifferentiated Arthritis https://ClinicalTrials.gov/show/NCT03666091 Active, not recruiting Societe Francaise de Rhumatologie 2005-04-19
NCT03662919 One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study https://ClinicalTrials.gov/show/NCT03662919 Recruiting Biogen 2022-06-30
NCT03663829 Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia https://ClinicalTrials.gov/show/NCT03663829 Active, not recruiting Bristol-Myers Squibb 2019-01-31
NCT03626116 Patient Satisfaction After Silicone Metacarpophalangeal Arthroplasty https://ClinicalTrials.gov/show/NCT03626116 Completed Schulthess Klinik 2018-12-19
NCT03631225 The Effect of Guided Care With Vectra DA Compared to Treatment as Usual in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03631225 Recruiting Myriad Genetic Laboratories, Inc. 2021-10-01
NCT03615729 RORC Genetic Polymorphism of Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03615729 Completed Assiut University 2018-03-30
NCT03616158 Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time https://ClinicalTrials.gov/show/NCT03616158 Recruiting National Jewish Health 2023-05-10
NCT03550833 Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Multifactorial and Integrative Psychological Model https://ClinicalTrials.gov/show/NCT03550833 Completed University Hospital, Bordeaux 2019-07-04
NCT03555240 Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03555240 Completed Istituto Ortopedico Rizzoli 2018-09-28
NCT03543488 Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease https://ClinicalTrials.gov/show/NCT03543488 Completed Federal University of Rio Grande do Sul 2013-11-20
NCT03535519 Rheumatoid Arthritis Response to Methotrexate https://ClinicalTrials.gov/show/NCT03535519 Recruiting Hospital General Universitario Gregorio Marañon 2020-08-31
NCT03540667 Study of Hip and Knee Arthroplasty in South Africa https://ClinicalTrials.gov/show/NCT03540667 Recruiting University of Cape Town 2020-11-30
NCT03457792 A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03457792 Recruiting Bristol-Myers Squibb 2021-03-12
NCT03452735 Fertility Study of Women With Chronic Inflammatory Rheumatism https://ClinicalTrials.gov/show/NCT03452735 Recruiting University Hospital, Toulouse 2019-07-31
NCT03444623 Survivin as Predictive Biomarker for RA https://ClinicalTrials.gov/show/NCT03444623 Recruiting Vastra Gotaland Region 2020-06-30
NCT03440892 Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT03440892 Recruiting Vastra Gotaland Region 2022-01-31
NCT03429426 Progression of Bone Erosions in Rheumatoid Arthritis Assessed by HR-pQCT and Conventional X-ray https://ClinicalTrials.gov/show/NCT03429426 Enrolling by invitation Aarhus University Hospital 2022-02-01
NCT03423953 Comprehensive Nano - PMCF Study https://ClinicalTrials.gov/show/NCT03423953 Recruiting Zimmer Biomet 2030-07-31
NCT03416543 Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03416543 Recruiting University Hospital, Tours 2020-12-31
NCT03411057 Mindfulness Based Stress Reduction in Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03411057 Enrolling by invitation Johns Hopkins University 2021-01-18
NCT01228812 Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls https://ClinicalTrials.gov/show/NCT01228812 Completed University of Lausanne 2010-09-30
NCT01211678 Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients https://ClinicalTrials.gov/show/NCT01211678 Completed Biogen 2013-07-31
NCT01187563 A Study of Tocilizumab in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01187563 Completed Regeneron Pharmaceuticals 2010-12-31
NCT01185522 An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS) https://ClinicalTrials.gov/show/NCT01185522 Completed Hoffmann-La Roche 2011-05-31
NCT01180361 Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance https://ClinicalTrials.gov/show/NCT01180361 Recruiting Winthrop University Hospital 2020-12-31
NCT01176682 Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder https://ClinicalTrials.gov/show/NCT01176682 Completed AstraZeneca 2011-08-31
NCT01166620 Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics https://ClinicalTrials.gov/show/NCT01166620 Completed Bristol-Myers Squibb 2011-09-30
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care https://ClinicalTrials.gov/show/NCT01163916 Completed Abbott 2011-11-30
NCT01163318 Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01163318 Completed AbbVie 2014-05-31
NCT01163292 Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467)) https://ClinicalTrials.gov/show/NCT01163292 Completed AbbVie 2012-10-31
NCT01156155 Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01156155 Completed University of Nebraska 2012-07-31
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey https://ClinicalTrials.gov/show/NCT01144598 Completed Abbott 2011-08-31
NCT01141413 Dose Escalation With Remicade® and Orencia® https://ClinicalTrials.gov/show/NCT01141413 Completed Bristol-Myers Squibb 2010-08-31
NCT01136707 Predictors of Adherence to Orencia https://ClinicalTrials.gov/show/NCT01136707 Completed Bristol-Myers Squibb 2010-07-31
NCT01137851 Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01137851 Completed Bristol-Myers Squibb 2010-09-30
NCT01137838 Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents https://ClinicalTrials.gov/show/NCT01137838 Completed Bristol-Myers Squibb 2010-10-31
NCT01136694 Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs) https://ClinicalTrials.gov/show/NCT01136694 Completed Bristol-Myers Squibb 2011-04-30
NCT01117480 Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA https://ClinicalTrials.gov/show/NCT01117480 Completed AbbVie 2014-12-31
NCT01102829 Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis Design https://ClinicalTrials.gov/show/NCT01102829 Completed Leiden University Medical Center 2010-04-30
NCT01105715 Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01105715 Completed University of Arkansas 2013-06-30
NCT01098201 Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT01098201 Completed University of Rochester 2014-07-31
NCT01095393 National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) https://ClinicalTrials.gov/show/NCT01095393 Enrolling by invitation UCB Pharma 2016-12-13
NCT01088360 Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) https://ClinicalTrials.gov/show/NCT01088360 Active, not recruiting Bristol-Myers Squibb 2029-06-30
NCT01088321 Safety Study of Abatacept to Treat Rheumatoid Arthritis (A) https://ClinicalTrials.gov/show/NCT01088321 Completed Bristol-Myers Squibb 2016-11-30
NCT01087125 Abatacept Pregnancy Exposure Registry https://ClinicalTrials.gov/show/NCT01087125 Recruiting Bristol-Myers Squibb 2019-12-31
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs https://ClinicalTrials.gov/show/NCT01083693 Completed Abbott 2010-06-30
NCT01086059 OTIS Autoimmune Diseases in Pregnancy Project https://ClinicalTrials.gov/show/NCT01086059 Active, not recruiting University of California, San Diego 2016-08-31
NCT01086033 A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece https://ClinicalTrials.gov/show/NCT01086033 Completed AbbVie 2012-07-31
NCT01081717 Golimumab Safety and Surveillance Program Using the Ingenix NHI Database https://ClinicalTrials.gov/show/NCT01081717 Completed Janssen Biotech, Inc. 2015-05-31
NCT01078597 A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA https://ClinicalTrials.gov/show/NCT01078597 Completed AbbVie 2013-07-31
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01078571 Completed Abbott 2010-05-31
NCT01077258 Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01077258 Completed AbbVie 2013-02-28
NCT01078558 A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) https://ClinicalTrials.gov/show/NCT01078558 Completed AbbVie 2018-01-11
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01076959 Completed Abbott 2011-06-30
NCT01076205 Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01076205 Completed AbbVie 2017-09-14
NCT01078402 EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries https://ClinicalTrials.gov/show/NCT01078402 Completed AbbVie 2011-11-30
NCT01075711 Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) https://ClinicalTrials.gov/show/NCT01075711 Completed Merck KGaA, Darmstadt, Germany 2010-09-30
NCT01078155 Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01078155 Completed AbbVie 2014-05-31
NCT01075477 An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab) https://ClinicalTrials.gov/show/NCT01075477 Completed Hoffmann-La Roche 2011-12-31
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT01078116 Completed Abbott 2010-06-30
NCT01078090 Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01078090 Completed AbbVie 2013-03-31
NCT01071798 An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01071798 Completed Hoffmann-La Roche 2014-10-31
NCT01069419 Observation of Treatment With Certolizumab Pegol in Daily Practice https://ClinicalTrials.gov/show/NCT01069419 Completed UCB Pharma 2014-09-30
NCT01070121 Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository https://ClinicalTrials.gov/show/NCT01070121 Completed University of Alabama at Birmingham 2012-08-31
NCT01060098 T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade https://ClinicalTrials.gov/show/NCT01060098 Completed Imperial College London 2012-12-31
NCT01044823 Use of Thermal and 3D Imaging to Quantify Arthritis https://ClinicalTrials.gov/show/NCT01044823 Completed University of Pittsburgh 2011-03-31
NCT01038349 Applications for Methotrexate Optimization in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01038349 Completed Cypress Bioscience, Inc. 2009-12-31
NCT01029613 Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers https://ClinicalTrials.gov/show/NCT01029613 Completed Glostrup University Hospital, Copenhagen 2013-07-31
NCT01001182 Health Outcomes in Rheumatoid Arthritis in Greece https://ClinicalTrials.gov/show/NCT01001182 Completed Pfizer 2012-06-30
NCT00989677 Rheumatoid Arthritis Disease Activity Monitor https://ClinicalTrials.gov/show/NCT00989677 Completed Maxima Medical Center 2009-06-30
NCT00990730 Atherosclerosis in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00990730 Completed University of California, San Francisco 2011-06-30
NCT00944320 Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan https://ClinicalTrials.gov/show/NCT00944320 Completed National Chung Hsing University 2007-02-28
NCT00944255 Pharmacogenetics of Antifolate Drugs in Autoimmune Diseases in Taiwan https://ClinicalTrials.gov/show/NCT00944255 Completed National Chung Hsing University 2008-02-29
NCT00938444 Evaluation of the BRADA and ABILHAND Questionnaires https://ClinicalTrials.gov/show/NCT00938444 Completed University Hospital, Ghent 2010-12-31
NCT00929357 Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment https://ClinicalTrials.gov/show/NCT00929357 Completed Pfizer 2010-06-30
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment https://ClinicalTrials.gov/show/NCT00902005 Completed Revmatismesykehuset AS 2011-06-30
NCT00895050 Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients https://ClinicalTrials.gov/show/NCT00895050 Completed Pfizer 2011-01-31
NCT00888576 Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan https://ClinicalTrials.gov/show/NCT00888576 Completed Pfizer 2011-12-31
NCT00881881 Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain https://ClinicalTrials.gov/show/NCT00881881 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2007-04-30
NCT00858169 Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler Ultrasonography https://ClinicalTrials.gov/show/NCT00858169 Completed Taichung Veterans General Hospital 2010-03-31
NCT00854321 Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital https://ClinicalTrials.gov/show/NCT00854321 Completed Kuopio University Hospital 2008-07-31
NCT00847236 Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica https://ClinicalTrials.gov/show/NCT00847236 Completed Lahey Clinic 2013-08-31
NCT00840957 Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00840957 Completed University Hospital, Tours 2009-11-30
NCT00832910 Assessment of Body Image in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00832910 Completed Federal University of São Paulo NA
NCT03100734 Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel https://ClinicalTrials.gov/show/NCT03100734 Completed Biogen 2018-11-30
NCT02968745 Occupational Performance Problems in Individuals With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02968745 Completed Federal University of Minas Gerais 2009-08-31
NCT02008266 Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02008266 Completed Hoffmann-La Roche 2012-12-31
NCT01111357 Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01111357 Completed University Hospital Center of Martinique 2010-08-31
NCT00815425 Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry) https://ClinicalTrials.gov/show/NCT00815425 Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2011-12-31
NCT01932372 Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01932372 Active, not recruiting Pfizer 2020-12-15
NCT01417455 Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01417455 Completed Instituto de Medicina Molecular João Lobo Antunes 2015-01-31
NCT03599986 Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03599986 Completed Eva Pharma 2018-10-13
NCT04036669 Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04036669 Completed King Saud University 2015-04-30
NCT01834807 A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01834807 Completed Hoffmann-La Roche 2013-08-31
NCT01641952 An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent https://ClinicalTrials.gov/show/NCT01641952 Completed Hoffmann-La Roche 2015-01-31
NCT01555879 Real-world Clinical Efficacy of Abatacept in the T3 Data Registry https://ClinicalTrials.gov/show/NCT01555879 Completed Arthritis Northwest PLLC 2016-11-30
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography https://ClinicalTrials.gov/show/NCT01476956 Active, not recruiting Canadian Research & Education in Arthritis 2018-12-31
NCT01476865 Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT01476865 Completed Federal University of São Paulo 2011-06-30
NCT00794118 Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose) https://ClinicalTrials.gov/show/NCT00794118 Completed Pfizer 2011-04-30
NCT03675516 Comorbidities and Outcomes in Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03675516 Completed Momentum Data 2019-01-01
NCT00793403 Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study https://ClinicalTrials.gov/show/NCT00793403 Completed Pfizer 2010-06-30
NCT00786227 Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA) https://ClinicalTrials.gov/show/NCT00786227 Completed Stanford University 2009-07-31
NCT00781989 Ultrasonography as a Biomarker in Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00781989 Completed Imperial College London 2011-04-30
NCT00781469 A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood https://ClinicalTrials.gov/show/NCT00781469 Completed Imperial College London 2010-10-31
NCT00760669 An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants https://ClinicalTrials.gov/show/NCT00760669 Completed Janssen Korea, Ltd., Korea 2011-04-30
NCT00751387 Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia https://ClinicalTrials.gov/show/NCT00751387 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-09-30
NCT00748254 Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis https://ClinicalTrials.gov/show/NCT00748254 Active, not recruiting University of Michigan 2021-01-31
NCT00748826 Remicade Safety Line (Study P03236)(COMPLETED) https://ClinicalTrials.gov/show/NCT00748826 Completed Merck Sharp & Dohme Corp. 2010-12-31
NCT00741104 A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) https://ClinicalTrials.gov/show/NCT00741104 Completed Merck Sharp & Dohme Corp. 2008-06-30
NCT00741793 Biologic Treatment Registry Across Canada https://ClinicalTrials.gov/show/NCT00741793 Completed Janssen Inc. 2018-06-27
NCT00725621 Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED) https://ClinicalTrials.gov/show/NCT00725621 Completed Merck Sharp & Dohme Corp. 2010-07-31
NCT00727298 Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) https://ClinicalTrials.gov/show/NCT00727298 Completed Merck Sharp & Dohme Corp. 2011-08-31
NCT00724243 Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) https://ClinicalTrials.gov/show/NCT00724243 Completed Merck Sharp & Dohme Corp. 2008-10-31
NCT00723905 Remicade Infusion Management Program https://ClinicalTrials.gov/show/NCT00723905 Completed Janssen Inc. 2012-10-31
NCT00721994 Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects https://ClinicalTrials.gov/show/NCT00721994 Completed Corin 2017-06-30
NCT00705289 A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) https://ClinicalTrials.gov/show/NCT00705289 Completed Merck Sharp & Dohme Corp. 2008-09-30
NCT00661284 A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) https://ClinicalTrials.gov/show/NCT00661284 Completed Chugai Pharmaceutical 2009-03-31
NCT00658827 Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis https://ClinicalTrials.gov/show/NCT00658827 Completed Janssen Biotech, Inc. 2016-09-30
NCT00619177 Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life https://ClinicalTrials.gov/show/NCT00619177 Completed Boehringer Ingelheim 2008-05-31
NCT00612885 Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study https://ClinicalTrials.gov/show/NCT00612885 Completed Boehringer Ingelheim 2005-08-31
NCT00594451 Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity https://ClinicalTrials.gov/show/NCT00594451 Completed University of Nebraska 2010-04-30
NCT00595894 Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans https://ClinicalTrials.gov/show/NCT00595894 Completed University of Nebraska 2012-07-31
NCT00522002 CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study https://ClinicalTrials.gov/show/NCT00522002 Completed George Washington University 2010-06-30
NCT00513591 Duke Autoimmunity in Pregnancy Registry https://ClinicalTrials.gov/show/NCT00513591 Completed Duke University 2018-11-19
NCT00503503 Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan https://ClinicalTrials.gov/show/NCT00503503 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2007-10-31
NCT00503139 Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan https://ClinicalTrials.gov/show/NCT00503139 Completed Pfizer 2013-04-30
NCT00488475 Observational Trial With Enbrel https://ClinicalTrials.gov/show/NCT00488475 Completed Pfizer 2013-04-30
NCT00484809 Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children https://ClinicalTrials.gov/show/NCT00484809 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00471874 Study Evaluating Health Related Utility in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00471874 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00440817 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn’s Disease. https://ClinicalTrials.gov/show/NCT00440817 Completed Centocor Ortho Biotech Services, L.L.C. 2006-08-31
NCT00443443 A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) https://ClinicalTrials.gov/show/NCT00443443 Completed Genentech, Inc. 2013-09-30
NCT00439894 Ancillary Study to Protocol 20060104 https://ClinicalTrials.gov/show/NCT00439894 Completed Amgen 2007-08-31
NCT00414661 Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550 https://ClinicalTrials.gov/show/NCT00414661 Completed Pfizer 2012-02-29
NCT00412399 Job Adaptation in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00412399 Completed Hospital for Special Surgery, New York NA
NCT00346411 Health Outcomes in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00346411 Completed Johns Hopkins University 2011-12-12
NCT00330889 Effects Of Prednisolone On Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT00330889 Completed GlaxoSmithKline 2006-12-31
NCT00267852 Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00267852 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2010-07-31
NCT00261976 A Long-term Safety Study of Infliximab (Remicade) https://ClinicalTrials.gov/show/NCT00261976 Completed Centocor, Inc. 2012-03-31
NCT00242853 A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00242853 Completed GlaxoSmithKline NA
NCT00245934 Study Evaluating Enbrel in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00245934 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00240136 Long-term Observation of Patients With Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00240136 Active, not recruiting University of California, Los Angeles 2022-12-31
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00234884 Completed Abbott 2010-07-31
NCT00213564 Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00213564 Completed University Hospital, Rouen 2004-05-31
NCT00213538 Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00213538 Completed University Hospital, Rouen 2016-12-31
NCT00195403 A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA https://ClinicalTrials.gov/show/NCT00195403 Completed Pfizer 2008-02-29
NCT00195377 Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain https://ClinicalTrials.gov/show/NCT00195377 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2006-04-30
NCT00195364 Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain https://ClinicalTrials.gov/show/NCT00195364 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2008-10-31
NCT00195338 Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg https://ClinicalTrials.gov/show/NCT00195338 Completed Pfizer 2010-12-31
NCT00121056 REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations https://ClinicalTrials.gov/show/NCT00121056 Completed Amgen NA
NCT00116727 Rheumatoid Arthritis DMARD Intervention and UtilizationStudy https://ClinicalTrials.gov/show/NCT00116727 Completed Amgen 2008-06-30
NCT00116714 Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy https://ClinicalTrials.gov/show/NCT00116714 Completed Amgen 2007-12-31
NCT00078793 Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00078793 Completed Amgen 2008-01-31
NCT00074555 Registry for African Americans With Early Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00074555 Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2011-12-31
NCT00071149 Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00071149 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00069472 Genetic Registry for Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00069472 Completed Northwell Health 2015-08-31
NCT00069342 Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT00069342 Completed National Institutes of Health Clinical Center (CC) NA
NCT00056602 Clinically Important Changes in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00056602 Completed National Institutes of Health Clinical Center (CC) 2018-03-01
NCT00001679 Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients https://ClinicalTrials.gov/show/NCT00001679 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001376 Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status https://ClinicalTrials.gov/show/NCT00001376 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001375 The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis https://ClinicalTrials.gov/show/NCT00001375 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001291 Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions https://ClinicalTrials.gov/show/NCT00001291 Completed National Institutes of Health Clinical Center (CC) NA
NCT00037336 Atherosclerosis in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00037336 Completed Vanderbilt University 2007-07-31
NCT00796809 Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis https://ClinicalTrials.gov/show/NCT00796809 Completed University of Arizona 2008-06-30
NCT00006333 Study of Arthritis and Related Conditions https://ClinicalTrials.gov/show/NCT00006333 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001885 Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001885 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001678 Genetics of Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001678 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001884 Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT00001884 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03297775 Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease https://ClinicalTrials.gov/show/NCT03297775 Recruiting University of Colorado, Denver 2027-06-30
NCT03214263 Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03214263 Recruiting Rigshospitalet, Denmark 2024-12-31
NCT03192267 Early Rheumatoid Arthritis Lung Disease Study https://ClinicalTrials.gov/show/NCT03192267 Recruiting University of Nebraska 2026-10-31
NCT03173144 Chronic Inflammatory Disease, Lifestyle and Treatment Response https://ClinicalTrials.gov/show/NCT03173144 Recruiting University of Southern Denmark 2019-03-31
NCT03099525 Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD) https://ClinicalTrials.gov/show/NCT03099525 Recruiting Hanyang University 2021-03-31
NCT03062865 French National Registry: ART REGISTRY (Observational Study) https://ClinicalTrials.gov/show/NCT03062865 Recruiting Assistance Publique - Hôpitaux de Paris 2024-11-30
NCT03011281 Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03011281 Recruiting Hanyang University 2020-12-31
NCT02813083 Detection of Pathological Lymphocytes in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT02813083 Enrolling by invitation University of Minnesota 2023-09-30
NCT02737449 Corrona Japan Rheumatoid Arthritis (RA) Registry https://ClinicalTrials.gov/show/NCT02737449 Enrolling by invitation Corrona, LLC. 2100-12-31
NCT02728934 Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02728934 Completed Janssen Scientific Affairs, LLC 2020-01-31
NCT02124031 Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR) https://ClinicalTrials.gov/show/NCT02124031 Completed Iniciativa Mexicana de Pacientes con Osteoartritis y Artritis Reumatoide 2015-08-31
NCT01793103 Brigham and Women’s Rheumatoid Arthritis Sequential Study https://ClinicalTrials.gov/show/NCT01793103 Recruiting Brigham and Women’s Hospital 2028-03-31
NCT01625650 Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study https://ClinicalTrials.gov/show/NCT01625650 Completed Corrona, LLC. 2015-05-31
NCT04347798 IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT https://ClinicalTrials.gov/show/NCT04347798 Enrolling by invitation University of Alberta 2021-04-30
NCT04278170 Sleep Quality in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04278170 Completed Istanbul Physical Medicine Rehabilitation Training and Research Hospital 2015-06-15
NCT03793660 Biologic National Registry https://ClinicalTrials.gov/show/NCT03793660 Recruiting Dacima Consulting 2020-05-23
NCT03687944 Unsupported Upper Limb Exercise Test in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03687944 Recruiting Pamukkale University 2019-04-15
NCT03456206 Chronic Inflammatory Disease, Lifestyle and Risk of Disease https://ClinicalTrials.gov/show/NCT03456206 Active, not recruiting University of Southern Denmark 2019-07-01
NCT02557295 An Observational Study to Evaluate Safety and Efficacy of Remsimaâ„¢ in Patients With RA https://ClinicalTrials.gov/show/NCT02557295 Recruiting Celltrion 2020-06-30
NCT00512239 Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset https://ClinicalTrials.gov/show/NCT00512239 Recruiting Université de Sherbrooke 2022-06-30